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Up to one quarter of human conceptions may be aneuploid, having too many or too few 
chromosomes relative to the standard 23 pairs. Most often this results from nondisjunction in 
maternal meiosis, making such errors a leading cause of pregnancy loss and congenital 
abnormalities. Prior research has established advanced age and altered patterns of meiotic 
recombination as risk factors for maternal meiotic nondisjunction and has shown that meiosis I 
and II errors may involve different mechanisms, but genetic risk factors have not been 
systematically investigated. The goal of this dissertation is to advance our knowledge of 
aneuploidy by identifying and characterizing common genetic variants associated with maternal 
meiotic nondisjunction of chromosome 21, the most common aneuploid condition in conceptions 
that survive to term. 
The first aim was to perform a candidate gene and genome-wide association study (GWAS) 
in which cases are mothers who have had a child with Down syndrome and controls are the fathers. 
We found plausible associations at variants at relevant loci. Stratifying by the stage of meiosis in 
which nondisjunction occurred (MI or MII), our results are consistent with general nondisjunction 
risk factors as well as some that could be specific for MI or MII. 
In the second aim, we called recombination events on chromosome 21 in our data set in 
order to classify cases (mothers) according to their recombination profiles. We therefore developed 
and implemented novel methods for calling recombination events in both trios and dyads, finding 
 v 
that full-data trios can be used to successfully train the method for calling recombination in dyads, 
which contain less information. 
The third aim was to further characterize the candidate gene and GWAS associations by 
performing stratified analyses in subgroups of mothers defined by recombination profile and 
maternal age. We interpret the associations in the context of possible meiotic error mechanisms. 
The public health significance of this research is its improvement of our understanding of 
the genetic architecture of meiotic errors, a leading factor in pregnancy loss and congenital defects. 
Eventually this could lead to identifying those at higher risk of meiotic errors and enabling more 
informed reproductive choices. 
 vi 
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1.0 INTRODUCTION 
1.1 BACKGROUND AND MOTIVATION 
1.1.1 Meiosis, Aneuploidy, and Established Risk Factors 
Human reproduction relies on the generation of haploid gametes during meiosis in order to 
form euploid offspring. But, due to meiotic nondisjunction, at least 10% (and potentially up to a 
quarter) of human conceptions are aneuploid, with the majority not surviving to term [1-5]. 
The higher rate of nondisjunction in women than in men reflects the different timescales 
on which meiosis operates in men and women. Oogenesis begins during development and pauses 
during prophase of meiosis I (MI) after recombination, with resumption at ovulation and 
completion of meiosis II (MII) after fertilization. Hence the duration of an oocyte’s arrest is 
essentially equal to a woman’s age at conception, and the risk of a meiotic error increases 
exponentially with age. Spermatogenesis, in contrast, begins at puberty, without a long period of 
arrest. (This topic is reviewed in [6].) 
Trisomy 21 (Down syndrome) is a useful condition to study for gaining insight into meiotic 
nondisjunction, since most other aneuploidies are not compatible with survival to term. Among 
live-born children with trisomy 21, over 90% of the nondisjunction events are maternal in origin, 
with about 75% due to apparent MI errors and 25% due to apparent MII errors [7]. Given the 
different timescales involved with completion of maternal MI and MII, it’s unsurprising that MI 
and MII nondisjunction have different risk factors. 
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In particular, altered patterns of recombination are a well-established risk-factor for 
maternal nondisjunction of most chromosomes, including chromosome 21 [8]. Specific to maternal 
chromosome 21 nondisjunction, both MI and MII errors are associated with altered recombination 
[9-13]. About half of MI errors show no recombination on chromosome 21, and those with a single 
exchange usually show telomeric recombination [9, 11, 14]. MII errors are associated with 
pericentromeric recombination [9, 11, 13, 14]. 
1.1.2 Possible Mechanisms and Genes of Interest 
As meiosis is a complex process with multiple steps and critical proteins, there are several 
opportunities for errors to occur that can result in trisomy. Here we review several mechanisms 
(see Figure 1.1, which was adapted from “Non-disjunction in Meiosis” by BioRender.com (2020) 
and retrieved from https://app/biorender.com/biorender-templates). 
 
Figure 1.1 Meiotic error mechanisms 
Conceptually, the simplest errors are “classical” MI or MII errors (often referred to in this 
dissertation and elsewhere simply as MI and MII nondisjunction/errors). In a classical MI error, a 
pair of homologs fails to disjoin at MI. Then, at MII, each homolog splits into two sister 
chromatids, so that the oocyte ends up with two non-sister chromatids. In a classical MII error, 
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homolog-pairs separate normally at MI, but sister chromatids fail to separate at MII, resulting in 
an oocyte with two sister chromatids. 
Another mechanism is premature/precocious separation of sister chromatids (PSSC). When 
sister chromatids separate too soon, they may segregate at random, independently of each other 
instead of to opposite poles in a coordinated fashion. If this occurs during MI, the oocyte may 
contain two non-sister chromatids, mimicking a classical MI error. If it occurs during MII, the 
oocyte may contain two sister chromatids, mimicking a classical MII error. 
Finally, reverse segregation (RS) occurs when sister chromatids segregate at MI instead of 
homologs, leading to a euploid intermediate containing two non-sister chromatids. At MII these 
may move together to the oocyte, resulting in an aneuploidy mimicking a classical MI error. 
Note that although PSSC and RS may mimic classical MI and MII errors, all of these 
mechanisms are distinct: chromatids or chromosomes fail to separate vs. separate too soon. The 
technique used in this dissertation cannot distinguish all of these error types from each other, but 
only whether there was an “apparent MI error” or an “apparent MII” error, according to whether 
the other passed two different or two identical copies of chromosome 21 to the child. Therefore, 
while distinct genetic risk factors may influence each mechanism, this study is not designed to 
prove or disprove which mechanism or variants caused each instance of aneuploidy. Patterns of 
association observed across different subgroups and the functions of implicated genes may 
nevertheless provide insight into these questions. 
To complement the genome-wide scan we performed for maternal meiotic nondisjunction, 
we also tested a set of candidate loci. These comprise well-established meiosis protein genes (e.g., 
synaptonemal complex and cohesin subunits) as well as loci associated with genome-wide 
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recombination counts in an Icelandic population [15] (see 2.3 for a discussion of the candidate 
loci). 
1.2 GENOTYPING ARRAY DATA IN THE CONTEXT OF DOWN SYNDROME 
In order to find genetic variants affecting the risk of maternal nondisjunction of 
chromosome 21 and its associated recombination patterns, we studied a group of children with 
Down syndrome and their parents. Genotype array data from these families serves several purposes 
in this study. First, chromosome 21 genotypes enable us to determine which parent contributed the 
child’s extra copy of chromosome 21 and the stage of meiosis in which the error apparently 
occurred (MI vs. MII). Second, we can infer the locations of recombination events on chromosome 
21, with the goal of categorizing nondisjunction events by recombination profile (discussed above 
as a known risk factor). Finally, genome-wide data allow us to systematically test the genome (and 
candidate regions) for association with nondisjunction, while stratifying by stage of error and 
recombination profile. 
1.2.1 Family Data and Informative Markers 
The parent and (with a few assumptions) the meiotic stage of origin for each nondisjunction 
event can be inferred by comparing the parents’ and children’s genotypes at markers along 
chromosome 21. For trios, the parents’ and children’s genotypes are all known, and the procedure 
is a straightforward extension of methods that have been used in previous studies using sparser 
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marker sets (see, e.g., [7, 16]). For mother-child dyads, which contain less information, a new 
method is described below. 
1.2.1.1 Methods for Trios 
To determine the parent of origin in a trio, we compare the child’s genotypes on 
chromosome 21 to the parents’. A marker (here, usually a SNP) is informative when one parent 
has genotype A/A and the other has genotype B/B (i.e., the parents are homozygous with different 
alleles; see Figure 1.2). In that case, the nondisjoining parent must transmit two identical alleles to 
the child, and the other parent transmits one copy of the other allele. Hence if the child’s genotype 
is A/A/B, then the nondisjoining parent is expected to be the parent with genotype A/A. Since any 
particular genotype is uncertain, here we used all informative SNPs on chromosome 21 and 
considered the proportion consistent with maternal nondisjunction. Allowing for genotyping error 
and mosaicism, we can determine that the mother was the nondisjoining parent whenever the 
proportion is near 1. 
 
Figure 1.2 Inferring parent of origin in a trio 
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Next, similar logic is used to infer the meiotic stage of origin for the trisomy in each trio. 
In MII nondisjunction, sister chromatids nondisjoin, so that the mother transmits two identical 
alleles to the child. In MI nondisjunction, homologous chromosomes nondisjoin, so that non-
identical alleles are transmitted. Hence a SNP is informative for the stage of error if the genotypes 
enable us to determine whether the two alleles passed from the mother to the child are identical or 
not. This occurs when the mother is heterozygous (A/B) and the other parent the father is 
homozygous (A/A, say). Figure 1.3 summarizes inference for stage of error. When the mother has 
passed two identical alleles for a SNP, the SNP is scored as reduced to homozygosity (R). If the 
two alleles are different, it is score as nonreduced (N). 
 
Figure 1.3 Determining meiotic stage of error in a trio 
In addition to assuming implicitly a meiotic (rather than mitotic) origin for each trisomy, 
we also assume that no recombination events are close enough to the centromere to go unobserved 
(i.e., more proximal than the nearest informative SNP). Then the zygosity (R or N) of the 
informative 21q SNPs nearest the centromere reflects the stage of error, R indicating an MII error 
and N indicating an MI error (21p SNPs are generally not informative). 
Plotting the state of each informative SNP (1 for N, 2 for R) vs. its physical chromosomal 
position, recombination events appear as changes in the “level” of the graph (e.g., …11112222…), 
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as in the upper panel of Figure 1.4. Manually inspecting the plots, we can flag apparent MII cases 
without recombination (i.e., graphs with 𝑦 = 2 for all SNPs, except for a few genotyping errors); 
these are often considered potentially mitotic and therefore excluded from analysis (Figure 1.4, 
lower panel). 
 
Figure 1.4 Examples of recombination profiles for two trios 
Calling recombination events involves a tradeoff between over- and under-sensitivity. A 
“switch” from R to N (or vice-versa) suggests a recombination event, but not every switch really 
signifies an event (Figure 1.5). On the one hand, a pattern like …NNNNNNRNNNN… would 
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indicate two recombination events very close to each other (“tight double recombination”), which 
is unlikely, given the relative likelihood of genotyping error (either in the child or one of the 
parents) and that of a true tight double recombination (given crossover interference). On the other 
hand, in a pattern like …NNNNNRRRRRNNNNN…, technical error is less likely to account for 
the apparent double recombination. More SNPs in the “middle segment” make the double 
recombination more plausible. 
 
Figure 1.5 Examples of recombination calls in two trios with genotyping “noise” 
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1.2.1.2 Methods for Dyads 
The approach described above for trios requires the genotypes of both parents, in addition 
to the child’s. Inference is still possible in a genotyped parent-child dyad, where one parent’s 
genotypes are unknown. Here we specifically consider mother-child dyads, in which the father’s 
genotypes are unknown (the mother’s nondisjunction and recombination phenotypes are analyzed 
downstream). 
As in trios, the parent of origin is first confirmed to be the mother in each case by 
considering the proportion of SNPs consistent with maternal nondisjunction. 
As in trios, a SNP is informative for stage of error only if the mother is heterozygous (A/B). 
If the child is homozygous (A/A/A or B/B/B), we infer that the mother transmitted two identical 
alleles and score the SNP as R. If the child’s genotype is A/A/B or A/B/B, the SNP is partially 
informative, since it can be inferred that the mother did not transmit B/B or A/A (respectively). In 




Figure 1.6 Informative markers in dyads 
For each dyad, we obtain a string of Rs and Xs representing the states of informative (or 
partially informative) SNPs near the centromere. As in trios, a string of Rs near the centromere is 
strong evidence of an MII error. But since SNPs in the N state can’t be observed directly (they’re 
masked as Xs, along with some R SNPs), we can infer MI errors only from the absence of R SNPs. 
Hence a higher ratio of Rs to Xs in a string is stronger evidence of an MII error (and a lower ratio 
is stronger evidence of an MI error). 
Similarly, recombination events are reflected by changes in the density of R vs. X along 
the chromosome. As in the case for trios, there is a problem of over- vs. under-calling 
recombination events, which is further complicated by the lower density of information. Although 
no particular X can be “unmasked” with certainty, the density of Rs nearby provides information. 
For instance, in the pattern …RRXR…, the X is likely to mask an R (an N would imply tight 
double recombination). But in a pattern such as …RRRRRXXXXXXXXXX…, the true state of 
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some of the Xs is probably N (if the state were truly R at each position, it would be unlikely to 
observe a long sequence of Xs). Hence a recombination event likely occurred. See Figure 1.7. 
 
Figure 1.7 Informative markers on chromosome 21 in a dyad 
Using this intuition, a higher density of Xs is evidence that the true state is N; 
recombination can be inferred when the density of Xs changes enough (by some measure). In this 
work we propose using a moving average to identify recombination events, calculating for each 
SNP the proportion of nearby informative SNPs scored X (Figure 1.8). This method leaves the 
number of SNPs to average over and the threshold as parameters to be optimized. To select the 
optimal parameters for this method, we apply it to the full-data trios, treating the fathers’ genotypes 
as missing and the recombination calls in the trios as correct. Full details are given in Section 3.7. 
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Figure 1.8 Using a moving average to call recombination events in a dyad 
1.2.2 Description of Data Set 
This study includes 2,186 subjects, comprising 749 children with trisomy 21 and most of 
their parents. Subjects were initially recruited using birth surveillance through the National Down 
Syndrome Project [7], a multi-site, population-based study, and later using convenience sampling. 
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Trisomy was confirmed by karyotyping; both full and mosaic trisomies are included, but not 
translocation trisomies. Genotyping was performed with the Illumina HumanOmniExpressExome-
8v1-2 array at CIDR, and after quality assurance/control about 1 million single nucleotide 
polymorphism (SNP) genotypes were available. Trisomic genotypes for SNPs on chromosome 21 
were called with previously-developed methods [17]. After imputation using the 1000 Genomes 
Project’s Phase I data and subsequent filtering, genotypes were available for about 9 million SNPs. 
Short tandem repeat (STR) marker genotypes were also available in some cases; STR genotyping 
was done historically as this cohort was recruited primarily to determine the parent and stage of 
origin of the trisomy. 
The dataset includes chromosome 21 SNP genotypes for 630 parent-child trios, 95 mother-
child dyads, and 17 father-child dyads. 
1.3 AIMS AND SUMMARY OF THIS DISSERTATION 
1.3.1 Finding Genetic Risk Factors for Nondisjunction 
The first aim of this dissertation is to identify genetic risk factors for maternal meiotic 
nondisjunction of chromosome 21 in either stage of meiosis. Chapter 2, which consists of a 
published genome-wide association and candidate gene study (see [18]), accomplishes this. 
Briefly, we performed a case-control study in which the mothers of children with Down syndrome 
are treated as cases and the fathers as controls. We found evidence that common variants at loci 
involved with oocyte maturation and meiotic processes may influence nondisjunction risk, with 
some specific to MI or MII. 
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1.3.2 Using Family Data to Call Recombination Events on Chromosome 21 
The second aim is to develop and implement methods for calling recombination events on 
chromosome 21 in parent-child trios and dyads. For trios this is quite straightforward; for mother-
child dyads where the fathers’ genotypes are unavailable, it is more challenging. As there is no 
“gold standard” for either case, we implement a simple method for trios and then use the resulting 
recombination calls as a “training set” to tune parameters in a novel method for calling 
recombination the dyads. We attain a high accuracy on the training set and conclude that it is 
feasible to call recombination events in mother-child dyads, resulting in a larger usable sample for 
association analyses (and potentially lower cost in future studies). Details of these recombination-
calling methods are given in the Appendix of Chapter 3, which has been published as part of [19]. 
1.3.3 Characterizing Genetic Risk Factors for Nondisjunction 
Our third aim is to dissect the associations discovered in the first aim. As apparent MI and 
MII errors may occur through different mechanisms, there may be genetic heterogeneity within 
each (apparent) type of error. Therefore we used the recombination calls from the second aim to 
classify each maternal nondisjunction event by its recombination profile on chromosome 21. This 
enabled us to perform stratified analyses of the loci found in the first aim, using the most important 
nondisjunction risk factors as stratification variables: maternal age and recombination profile. We 
find evidence consistent with genetic heterogeneity and attempt to interpret our results in the 
context of possible mechanisms. The third aim is accomplished in Chapter 3, consisting of a second 
published study (see [19]). 
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2.0 A CANDIDATE GENE ANALYSIS AND GWAS FOR GENES ASSOCIATED WITH 
MATERNAL NONDISJUNCTION OF CHROMOSOME 21 
This chapter has been published in PLoS Genetics. Per PLoS license and copyright policy 
(https://journals.plos.org/plosgenetics/s/licenses-and-copyright), the article is reproduced here 
under a Creative Commons BY license with minor formatting and non-scientific changes. The 
original article and supporting information are available online at 
https://doi.org/10.1371/journal.pgen.1008414. 
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2.1 CHAPTER OVERVIEW 
Human nondisjunction errors in oocytes are the leading cause of pregnancy loss, and for 
pregnancies that continue to term, the leading cause of intellectual disabilities and birth defects. 
For the first time, we have conducted a candidate gene and genome-wide association study to 
identify genes associated with maternal nondisjunction of chromosome 21 as a first step to 
understand predisposing factors. A total of 2,186 study participants were genotyped on the 
HumanOmniExpressExome-8v1-2 array. These participants included 749 live birth offspring with 
standard trisomy 21 and 1,437 parents. Genotypes from the parents and child were then used to 
identify mothers with nondisjunction errors derived in the oocyte and to establish the type of error 
(meiosis I or meiosis II). We performed a unique set of subgroup comparisons designed to leverage 
our previous work suggesting that the etiologies of meiosis I and meiosis II nondisjunction differ 
for trisomy 21. For the candidate gene analysis, we selected genes associated with chromosome 
dynamics early in meiosis and genes associated with human global recombination counts. Several 
candidate genes showed strong associations with maternal nondisjunction of chromosome 21, 
demonstrating that genetic variants associated with normal variation in meiotic processes can be 
risk factors for nondisjunction. The genome-wide analysis also suggested several new potentially 
associated loci, although follow-up studies using independent samples are required.  
2.2 AUTHOR SUMMARY 
Approximately one of every 700 babies is born with trisomy 21 - an extra copy of 
chromosome 21. Trisomy 21 is caused by the failure of chromosomes to segregate properly during 
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meiosis, generally in the mother. Past studies have defined altered patterns of recombination along 
nondisjoined chromosomes as risk factors for human nondisjunction and model systems have 
clearly shown that specific genes involved recombination and other early meiotic processes play a 
role in the fidelity of chromosome segregation. However, no genome-wide genetic study (GWAS) 
has ever been conducted using maternal human nondisjunction as the disease phenotype. This 
study takes the first step to understand predisposing factors. We used chromosome 21 genotypes 
from the parents and child to identify mothers with nondisjunction errors derived in the oocyte and 
to establish the type of error (meiosis I or meiosis II). We then conducted a unique set of subgroup 
comparisons designed to leverage our previous work that shows that the etiologies of meiosis I 
and meiosis II nondisjunction differ for trisomy 21. Both the candidate gene study and the GWAS 
provide evidence that meiotic-specific structures and processes are vulnerable to genetic variants 
that lead to increased risk of human chromosome nondisjunction. 
2.3 INTRODUCTION 
Correct segregation of chromosomes during the two successive meiotic divisions is 
essential for the formation of haploid gametes. At least 10% of human pregnancies produce 
aneuploid embryos with too many or too few chromosomes, the majority of which are lost during 
pregnancy. If they survive to term, many have severe congenital defects and developmental and 
intellectual disability. Thus, meiotic nondisjunction is the leading cause of pregnancy loss and 
birth defects in humans and an important limiting factor in women’s reproductive life span. 
(reviewed in [1, 2, 4, 5, 13]).  
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In humans, meiosis in females is highly prone to chromosome segregation errors i.e., 
nondisjunction or premature separation of sister chromatids (PSSC) and these errors increase 
exponentially with increasing maternal age. The differences between the development of oocytes 
and sperm clearly influence susceptibility for meiotic nondisjunction. Most importantly, they work 
on different timelines. In both sexes, meiosis starts with an initial step of DNA replication and the 
establishment of sister chromatid cohesion, followed by synapsis and recombination between 
homologous chromosomes. Homologs then separate at the end of meiosis I (MI), whereas sister 
chromatids separate in meiosis II (MII). Spermatogenesis begins after puberty and cells entering 
meiosis move from one stage to the other without delay. In contrast, oogenesis begins during fetal 
development and is arrested in prophase I after chromosomes synapse and recombine. MI resumes 
in the woman’s adult life just before the ovulation; MI is completed and the first polar body is 
extruded. MII begins but arrests for a short period as the oocyte travels through the Fallopian tubes, 
and is only completed if the oocyte is fertilized. Thus, meiosis in females extends over a 10 to 50 
year period; the age of the woman at conception reflects the age of the oocyte, and basically the 
period of arrest in MI. Given the mechanistic differences and temporal separation of maternal MI 
and MII, it is not surprising that associated risk factors differ for MI and MII nondisjunction errors 
(reviewed in [6]).    
Trisomy 21 has become an important resource to understand meiotic nondisjunction in 
humans, as it is one of the few aneuploid conditions that survives to term. However, even for 
trisomy 21, involving the smallest human autosome, about 50-80% conceptions are estimated to 
be lost during pregnancy [5, 20]. Using chromosome 21 genetic markers to categorize the type of 
meiotic error among live births with trisomy 21, over 90% are derived from errors in the oocyte, 
of which at least 75% are estimated to be initiated in MI and about 25% in MII (e.g., [7]).  
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In this study, our goal was to discover genetic variants that increase the risk for maternal 
nondisjunction of chromosome 21 using both a candidate gene approach and a genome-wide 
association study. We focused on candidate genes that have been associated with chromosome 
dynamics early in meiosis. Accurate segregation depends on the coordinated control of sister 
chromatid cohesion with chromosome synapsis and the assembly of the synaptonemal complex 
(SC) and, within these structures, meiotic recombination [21, 22]. Below we provide a brief 
overview of the role of some of the important meiotic genes that mediate these processes, and that 
we have examined in the present study. Bolcun-Filas and Schimenti [21] have summarized the 
meiotic defects that are observed in the associated mutant mouse models. 
In a meiotic cell, DNA is organized as an array of loops along a proteinaceous axis. The 
axes are composed of the meiosis-specific synaptonemal complex, in association with 
condensin/cohesin complexes. Several of the components of meiotic cohesin are meiosis-specific, 
including those encoded by SMC1β, REC8, RAD21L, and STAG3. The SC brings homologous 
chromosomes into close proximity and promotes recombination and chiasmata formation [23]. 
The mature SC is a tripartite structure, composed of two parallel axial/lateral elements that bind to 
each homolog and a central element, with transverse filaments joining the individual axial/lateral 
elements [24, 25]. SYCP2 and SYCP3 are components of the axial/lateral elements. SYCP1 is a 
component of the transverse filaments and components of the central element are encoded by 
SYCE1, SYCE2, SYCE3, and TEX12. In addition to these structural sub-units, HORMAD1 and 
HORMAD2 code for proteins that load onto axes of meiotic chromosomes throughout early 
prophase I but are removed upon synapsis, a process that depends on the presence of TRIP13 [26]. 
In general, HORMAD1 and HORMAD2 play a role in coordinating progression of chromosome 
synapsis with meiotic recombination [27].   
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Meiotic recombination is initiated by programmed DNA double-strand breaks (DSBs) that 
occur as the meiotic chromosome axes develop early in prophase I. These breaks are generated by 
the SPO11 protein and its interacting partners MEI1, MEI4 and REC114 (reviewed in Cole et al. 
[28]). The DSBs are processed to generate single-stranded DNA that is bound by strand-exchange 
proteins DMC1 (meiosis specific) and RAD51 (ubiquitously expressed). The single-stranded DNA 
then engages in homology search. Proper function of DMC1 requires interactions with several 
meiotic accessory proteins, one of which is MND1. MND1, complexed with HOP2, stabilizes the 
DMC1 filaments on the resected end of the DSBs. This complex also increases the ability of the 
pre-synaptic filament to capture the double-stranded DNA (reviewed in Sansam and Pezza [29]). 
As homologs synapse, so-called early recombination nodules transiently associate with 
ZMM proteins, including DNA mismatch repair proteins MSH4 and MSH5. Subsequently, a 
proportion of these are converted into late recombination nodules, detected by the mismatch repair 
proteins MLH1 and MLH3, and representing the vast majority of crossovers [30-34]. In addition, 
EXO1 and BLM function in crossover regulation, and with MLH1 and MLH3, appear to play a 
role in the crossover pathway that is subject to crossover interference (reviewed in Manhart and 
Alani [35]). 
In addition to these candidate genes, we chose another group of genes that have been 
associated with the amount of global meiotic recombination in humans. The motivation for these 
candidates is based on the altered recombination patterns observed along nondisjoined 
chromosomes, a well-established predisposing factor for maternal nondisjunction of almost all 
human chromosomes studied to date (reviewed in [8]). Specifically for maternal chromosome 21 
nondisjunction, altered meiotic recombination patterns are associated with both MI and MII error 
types [9-13]. For maternal MI-derived trisomy 21, about 40-47% of MI cases are derived from 
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oocytes with no meiotic exchange [9, 11, 14]. Among those with a single exchange, the majority 
of exchanges occur in the telomeric region of chromosome 21. MII errors are associated with 
pericentromeric exchanges [9, 11, 13, 14]. This apparent effect of an MI process – recombination 
– on MII nondisjunction suggests that at least a portion of so-called MII errors may have their 
origin in MI. In addition, there is evidence that genome-wide recombination counts in oocytes with 
a MI nondisjunction error of chromosome 21 are reduced compared to oocytes with normal 
meiosis [36, 37]. Also, previous studies indicate that oocyte-specific dysregulation of global 
recombination may contribute to the nondisjunction event [36]. Thus, we chose candidate genes 
identified in the largest GWAS study of meiotic recombination conducted on humans, a study 
based on 71,929 parent-offspring pairs from Iceland [15]. They found evidence for 13 variants in 
eight regions that were associated with genome-wide recombination counts. 
For both the candidate gene and genome-wide association studies, we took a unique 
approach by using several different GWAS group comparisons (Table 2.1). These comparisons 
were crafted to address the likelihood that there are both distinct genetic factors influencing MI 
and MII nondisjunction and common factors affecting both. In addition, some of our analyses 
target the conflated phenotype of nondisjunction with survival to term. Study design issues are 
discussed in more detail below. 
Table 2.1 Description of primary analyses and sample sizes 
Analysis Analysis groups Sample size Contrast able to detect: 
Logistic regression Mothers vs. fathers 705 vs. 645 Maternal NDJ and survival to term 
... MI mothers vs. fathers 535 vs. 645 MI-specific effects and survival to term 
... MII mothers vs. fathers 157 vs. 645 MII-specific effects and survival to term 
... MI mothers vs. MII mothers 535 vs. 157 MI- or MII-specific effects 




2.4.1 Study Sample 
Our study participants included 749 live born offspring with free (non-translocation), 
maternally-derived trisomy 21 (both full and mosaic trisomy 21 were included) and their available 
biological parents. In almost all instances, the trisomy was confirmed by karyotype, although in 
some it was confirmed by birth record or parent report. Recruitment occurred in the U.S. by 
multiple sites since 1989, when the first population-based study was initiated. Recruitment for 
these population-based studies used birth surveillance systems to identify infants born with Down 
syndrome (details are provided in Freeman et al. [7]). Later, our recruitment strategy was not 
population-based, but instead a convenience sample of families with Down syndrome identified 
through our network of assessment sites, social and website media, and parent groups. Using self-
reported race/ethnicity, 72% reported as White, 4% as Hispanic descent, 2% as African/African-
American or Asian descent and about 23% with other or unknown descent.  
2.4.1.1 Ethics Statement 
Participants were recruited from several geographic areas with the collaboration of several 
institutions, including Arkansas (University of Arkansas for Medical Sciences, Arkansas Center 
for Birth Defects Research and Prevention, Arkansas Children’s Hospital, Arkansas Reproductive 
Health Monitoring Systems), California (California Birth Defects Monitoring Program, Public 
Health Institute), Georgia (Department of Human Genetics, Emory University; Centers for Disease 
Control and Prevention), Iowa (University of Iowa, Registry for Congenital and Inherited 
Disorders), New Jersey (New Jersey Department of Health and Senior Services; Special Child 
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Health Services Registry; Eagleton Institute), and New York (New York State Department of 
Health Congenital Malformations Registry). Each recruitment site obtained IRB approval for their 
protocol, consent forms, and data sharing during the project period from their respective 
institutions. All samples were collected under written consent by each participant or their legal 
guardian. Emory University was the site for the data and biorepository. They obtained IRB 
approval for all sample processing and de-identified sample submission to the Center for Inherited 
Disease Research genotyping service (Emory School of Medicine IRB number IRB00005100). 
IRB approvals for genotyping samples and uploading to dbGaP were approved prior to the 
initiation of that genotyping project (dbGaP: phs000718). 
2.4.1.2 Genotyping 
DNA samples were obtained from lymphoblastoid cell lines (LCLs) (36.8%), saliva 
(23.7%), buffy coat (15.7%), whole blood (13%), unknown source (i.e., no record available) 
(8.4%), and buccal cell (0.09%). The remaining 2.2% of genotyped samples were HapMap 
controls derived from LCLs that were used by the Center for Inherited Disease Research (CIDR) 
for quality control (QC). The samples were genotyped in batches corresponding to 96-well plates 
and each plate contained two study duplicates and HapMap controls. Duplicates were randomly 
selected from all samples with sufficient DNA. Families were randomly distributed across plates 
with all members of each family on the same plate. 
Genotyping was performed on the Illumina HumanOmniExpressExome-8v1-2 array by the 
Center for Inherited Disease Research (CIDR). The algorithm used for calling genotypes was 
GenomeStudio version 2011.1, Genotyping Module version 1.9.4 and GenTrain version 1.0. 
Genotype data that passed initial QC at CIDR were released to the Quality Assurance (QA)/QC) 
analysis team at the University of Washington Genetics Coordinating Center (UWGCC) for data 
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cleaning and imputation. Details of these procedures can be found in Laurie et al. [38] and all data 
are available in dbGaP along with specifics of genotyping and QC (dbGaP: phs000718). After QC, 
genotypes were available for 2,186 unique study participants. We filtered SNPs based a deviation 
of Hardy-Weinberg equilibrium (HWE) at p < 10-6. Overall, the median call rate was 99.86% and 
the error rate estimated from 53 pairs of study sample duplicates is 1x10-4. All samples had a 
missing call rate < 2%. The percent of SNPs with a minor allele frequency (MAF) of < 2% was 
30% for the autosomes and 32.1% for the X chromosome. This calculation was based on all study 
participants for SNPs not located on chromosome 21 and on only study parent samples for SNPs 
on chromosome 21. Trisomic genotypes for all 749 children in the study were called from raw 
genotyping data with previously-developed methods [17].   
Possible chromosomal abnormalities beyond trisomy 21 were examined as possible 
artifacts of the use of DNA from LCLs. This was done using “Log R Ratio” (LRR) and “B Allele 
Frequency” (BAF) [39, 40] and applying the methods outlined in Laurie et al. [41]. Regions or 
chromosomes containing identified anomalies were excluded for genotype imputation purposes 
(see below). For chromosomes other than chromosome 21, 50 large anomalies were identified, of 
which 15 were filtered out of the dataset by setting genotypes in the identified region to missing. 
In addition, Mendelian inconsistencies were examined and one additional family was identified to 
have a genotype pattern consistent with uniparental chromosome 16 in the offspring. Genotypes 
at this chromosome were also set to missing. 
Seven participants with neither parent genotyped were excluded from subsequent analyses. 
Thus in the remaining 742 families, genotypes were available for both the child and either the 
mother only (n = 95), the father only (n = 17), or both parents (n = 630).  
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2.4.1.3 Adjustment for Population Structure 
Binary trait analyses using logistic regression are our primary statistical approach in this 
GWAS study. To adjust for population structure, we first used principal components analysis 
(PCA) as described by Patterson et al. [42], and implemented in R (SNPRelate package). SNPs 
used for PCA were selected by LD pruning from an initial pool that included all non-chromosome 
21 autosomal SNPs with a missing call rate < 5% and MAF > 5%. In addition, the 2q21 (LCT), 
HLA, 8p23, and 17q21.31 regions were excluded from the initial pool. The first three eigenvectors 
were used in subsequent analyses.  
2.4.1.4 Imputation 
The UWGCC used IMPUTE2 software [43] to perform genotype imputation. Details of 
their methods and QC are available at dbGaP:phs000718. The worldwide reference panel of 1,092 
samples from the 1000 Genomes Project’s Phase I integrated variant set [44] was used for 
imputation. We included only imputed variants with a quality metric of ≥ 0.3, as previously 
recommended [45].  
2.4.1.5 Phenotyping 
Our primary association studies were based on mothers who had a live birth with full or 
mosaic trisomy 21 as determined by karyotype and then determined to be due to a maternal 
nondisjunction error based on the characterization of the chromosome 21 genotype contributions 
from parent to the child with trisomy 21. Genotypes were obtained from the Illumina 
HumanOmniExpressExome-8v1-2 array and from previously genotyped variants along 
chromosome 21 using both STRs and SNPs [11, 13] The groups based on maternal nondisjunction 
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errors were compared with fathers of the children with trisomy 21 who represent a random group 
of individuals from the population. 
Methods for defining the type of nondisjunction errors are described in detail in our 
previous work (e.g., [11, 13]). Briefly, parental origin of the meiotic error (maternal or paternal) 
was first determined by establishing the contribution of informative parental chromosome 21 
genotypes to the child with trisomy 21. In families with both parents genotyped and where the 
parent of origin was unambiguously confirmed to be the mother (the vast majority of these 
families), we defined the meiotic stage of origin. We scored the genotype at each informative SNP 
and STR marker on chromosome 21q as either reduced to homozygosity (R) or not (N), according 
to whether the mother transmitted two identical or two different alleles, respectively, to her child 
at that locus. The meiotic stage of nondisjunction (MI or MII) was called according to the zygosity 
at the loci most proximal to the centromere (N or R, respectively). In a few cases (n=7), MII 
nondisjunction was called on the basis of a single, well-genotyped R SNP nearest the centromere 
(followed by a series of N SNPs), but because of the dense SNP genotyping on the chip, stage was 
more typically supported by many markers. 
In families with only one parent genotyped, a slightly different approach was required, as 
missing parental data led to some markers that are partially informative, but not dispositive of 
zygosity. Briefly, we considered the ratio of information in the SNPs near the centromere, and 
called each case as MI or MII depending on the ratio. The threshold for this ratio was selected by 
performing an experiment with the complete trios; for each complete trio, we masked the genotype 
of one parent, calculated the ratio described above, and found the cutoff that optimized the 
predictive accuracy.  
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Lastly, when all informative markers in the parent of origin were reduced to homozygosity 
along 21q, the origin of error was inferred to be a post-zygotic, mitotic error and the case was 
excluded from this study, consistent with previous studies [9]. However, we recognize that a 
proportion of these cases may be MII nondisjunction errors with no recombination.  
2.4.2 Analysis 
2.4.2.1 Sample Size 
As described above, samples from 2,186 participants were genotyped for this study, 
comprising 749 children and 1,437 parents. Participants with unresolved identity swaps, probands 
(children) with neither parent genotyped, and mothers in cases of potentially mitotically-arising 
trisomy were excluded from GWAS. After this filtering, 705 mothers and 645 fathers were retained 
for analysis, comprising 612 complete parent-child trios. Meiotic stage of origin for trisomy was 
determined to be MI in 535 cases, MII in 157 cases, and was not determined in 13 cases. Sample 
sizes for our analysis groups are reported in Table 2.1. 
2.4.2.2 Association Studies 
We performed five primary GWAS analyses (summarized in Table 1). The comparison for 
all mothers vs. fathers can identify maternal genetic factors influencing nondisjunction either in 
MI or MII (or, more powerfully, in both). As noted in the Introduction, some genetic factors 
affecting MI nondisjunction may be shared with MII nondisjunction. Comparison of MI-only or 
MII-only mothers with fathers can identify maternal genetic factors influencing MI nondisjunction 
or MII nondisjunction, respectively. All three of these comparisons will also detect maternally-
derived variants affecting survival of the infant to term. We chose to use fathers within our own 
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study as controls rather than turning to external controls because of the significant problem with 
confounding (chip and study effects) that is introduced when cases genotyped in one study are 
compared to controls genotyped in another. 
However, one risk of using fathers as controls is that in theory the three analyses that 
compare mothers to fathers may also identify spurious associations due to comparing females to 
males. We tested this by running a female vs. male GWAS in a large additional dataset and 
comparing our results to those. The dataset we used was a subset of the COHRA study [46]; this 
study targeted dental phenotypes, but participants were selected in a community-based setting 
without regard to phenotype. We used 456 male and 494 female unrelated self-identified white 
adults in order to have a sample size comparable to the current study. By using sex as the outcome 
measure in a sample that was unselected with regard to phenotype, this analysis gave us a set of 
results to compare to our trisomy dataset in order to determine whether any of our trisomy results 
might instead be male vs. female artifacts. The female vs. male analysis in the COHRA dataset did 
not result in any unusually significant differences (lambda = 0.94). None of the GWAS loci or 
candidate genes described in the results section appeared among the largest differences between 
males and females in the COHRA dataset. The Manhattan plot and QQ plots are provided in the 
Supporting Information (S1 Figure), as well as results from the COHRA analysis in our candidate 
genes (S1 Table). 
The fourth comparison involves MI vs. MII mothers. This comparison has the potential to 
identify unique factors for MI or MII nondisjunction without confounding by trisomy 21 survival; 
that is, both groups of mothers had a live birth child with trisomy 21.  
For the fifth analysis, we conducted a transmission disequilibrium test (TDT) [47]. This 
test examines the association between the child’s genotype and the dual phenotype of 
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nondisjunction and survival to term. Our prior hypothesis is that this test is best for identifying 
fetal “survival genes.” If there is association between maternal genotype and either nondisjunction 
or survival, this test can in theory identify it, but the association would be weakened. We did not 
perform this test for the candidate genes, since they were chosen as candidates for nondisjunction, 
not for survival. For the nondisjoined chromosome 21, we used a trisomic TDT, previously 
developed by our group [48]. 
For all analyses except the TDT, we used the logistic regression model logit(p) = SNP + 
PC1 + PC2 + PC3, where SNP is encoded additively and PC1, PC2, and PC3 are the first three 
principal components of ancestry. The X chromosome was not examined because our primary 
comparative analyses involved mothers vs. fathers.   
For all analyses, we filtered out SNPs with MAF < 1% or with extreme departure from 
HWE. Imputed SNPs with info score < 0.5 were also excluded, and imputed genotypes called with 
less than 90% confidence were coded as missing. Analyses were performed with PLINK and R. 
2.4.2.3 Maternal Age Effect 
Because of the strong maternal age effect in maternal chromosome 21 nondisjunction, it is 
important to consider how maternal age fits into the above analyses. Previous results from our 
group and others suggest not only different etiologies for MI and MII nondisjunction, but likely 
different etiologies in different age groups. Statistically, this would suggest a model that includes 
not only maternal age effect but also an age X genotype interaction term. However, since our 
primary analyses compare mothers to fathers, it is not possible to fit such a model (since fathers 
have no “maternal age”). The logical analysis, then, is to stratify by maternal age group, similar to 
the approach we took for the MI and MII subgroups. We performed several such analyses, but the 
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sample sizes were prohibitively small for interpretation. We elaborate further on this issue in the 
Discussion.   
2.4.2.4 Candidate Gene Analyses 
For candidate gene analyses, we examined a window of 60kb on each side of the gene or 
SNP. We used a statistical significance cutoff based on the method of Li and Ji [49], which 
calculates the equivalent number of independent SNPs in the region and applies a Bonferroni 
correction based on that number. Thus the candidate gene analyses are fully corrected for multiple 
testing at the level of each individual gene. 
2.4.2.5 Follow-up Analyses to Examine Top-Ranked GWAS Signals 
For follow-up analyses of signals of p < 10-5 for the GWAS, we performed literature 
searches on genes within 500kb. For each of those regions, LocusZoom plots were created in all 
analyses to identify common associations across analyses. 
2.5 RESULTS 
2.5.1 Candidate Gene Association Studies 
We focused on two sets of candidate genes/regions: genes that function in early stages of 
meiosis and that have been associated with accurate chromosome segregation (n=24) and regions 
associated with human recombination genome-wide counts (n=8) [15]. The Bonferroni-corrected 
statistical significance cutoffs along with all results are shown in Table 2.2 and LocusZoom plots 
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are provided in Figures 2.1-2.5 and in the Supporting Information (S2-S9 Figures). Each row in 
Table 2.2 represents one candidate locus. Each column represents an analysis. For each cell in the 
table, the most significant association at the locus (not always unique) is reported. P-values 
significant after correcting for multiple testing are marked with an asterisk and highlighted. Note 
that for each analysis in each gene, Table 2.2 lists the most statistically significant result, so that 
the SNP that appears in a given gene is not necessarily the same in each analysis. More detailed 
results are shown in the Supporting Information (S2 Table). 
















SYCP1 P=0.00238 P=0.00255 P=0.002 P=2.69e-05* 9.43e-04 
SYCP2 P=0.017 P=0.00592 P=0.000735* P=3.09e-05* 8.62e-04 
SYCP3 P=0.0078 P=0.00748 P=0.00637 P=0.00151 9.43e-04 
SYCE1 P=0.0336 P=0.022 P=0.0227 P=0.00222 1.35e-03 
SYCE2 P=0.00146 P=0.000425* P=0.0154 P=0.00655 1.14e-03 
SYCE3 P=0.00324 P=0.000764 P=0.0053518 P=0.00337 5.38e-04 
TEX12 P=0.00558 P=0.0219 P=0.013871 P=0.0271 1.19e-03 
BLM P=0.0225 P=0.0378 P=0.00601 P=0.0257 7.04e-04 
DMC1 P=0.0184 P=0.00993 P=0.018619 P=0.0134 1.19e-03 
EXO1 P=0.00924 P=0.0118 P=0.00111 P=0.00303 6.10e-04 
HORMAD1 P=0.0152 P=0.0174 P=0.011377 P=0.00361 1.35e-03 
HORMAD2 P=0.0113 P=0.0156 P=0.00155 P=0.00838 8.93e-04 
MEI1 P=0.00655 P=0.0485 P=0.00951 P=0.0204 9.26e-04 
MEI4 P=0.0147 P=0.0164 P=0.0283 P=0.021 6.33e-04 
MLH1 P=0.0151 P=0.00297 P=0.0162 P=0.0427 1.14e-03 
MLH3 P=0.00472 P=0.0107 P=0.0241 P=0.0207 1.35e-03 
MND1 P=0.0273 P=0.013 P=0.000336* P=9.6e-05* 8.77e-04 
MSH5 P=0.00677 P=0.00135 P=0.0417 P=0.0241 9.26e-04 
REC114 P=0.0187 P=0.0272 P=0.0886 P=0.0118 8.77e-04 
REC8 P=0.00822 P=0.00404 P=0.00195 P=0.00112 9.43e-04 
SMC1B P=0.0115 P=0.00407 P=0.047 P=0.0349 7.81e-04 
SPO11 P=0.0232 P=0.0325 P=0.0115 P=0.0181 1.25e-03 
STAG3 P=0.005 P=0.00472 P=0.0798 P=0.00958 1.19e-03 
TRIP13 P=0.0026 P=0.0122 P=0.00358 P=0.0206 1.61e-03 
rs1254319 
(C14orf39 missense) P=0.0278 P=0.0488 P=0.0372 P=0.00464 1.39e-03 
rs75502650 
(CCDC43 intron) P=0.00203 P=0.00137* P=0.000628* P=0.031 7.58e-04 
rs1132644 
(CCNB1IP1 UTR) P=0.0232 P=0.00657 P=0.0236 P=0.0195 1.32e-03 
rs56162163 
(chr17 inversion) P=0.00666 P=0.00956 P=0.00737 P=0.0166 6.67e-04 
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rs74434767 
(CPLX1 intron) P=0.00611 P=0.0178 P=0.0227 P=0.0329 1.61e-03 
rs5745459 
(MSH4 missense) P=0.0389 P=0.0283 P=0.037 P=0.0198 1.16e-03 
rs150798754 
(PRDM9 intergenic) P=0.00219 P=0.006 P=0.0123 P=0.022 1.25e-03 
rs6889665 
(PRDM9 upstream) P=0.00219 P=0.006 P=0.0104 P=0.0678 8.33e-04 
rs450739 
(RAD21L missense) P=2.49e-05* P=7.47e-05* P=0.00579 P=0.00126 1.09e-03 
rs4045481 
(RNF212 missense) P=0.00475 P=0.0136 P=0.00514 P=0.0131 1.02e-03 
rs658846 
(RNF212 intron) P=0.00292 P=0.0108 P=0.00514 P=0.0131 8.33e-04 
rs12233733 
(RNF212 nearby) P=0.00292 P=0.0108 P=0.00396 P=0.031 1.52e-03 
rs10135595 
(SMEK1 UTR) P=0.0125 P=0.007 P=0.00306 P=0.000183* 1.39e-03 
Each row represents one candidate locus (either a gene with a 60kb border on each side or a 60kb 
window around a SNP). Each column represents an analysis. For each locus-analysis pair, the 
most significant association at the locus (not always unique) is reported. P-values significant after 
correcting for multiple testing (i.e., exceeding the Bonferroni-adjusted significance threshold 
noted in the last column) are marked with an asterisk and highlighted. (MI: meiosis I; MII: 
meiosis II; P: p-value; OR: odds ratio.) The first 24 loci represent genes selected for their function 
(above the double line). The latter 13 loci represent SNPs identified by Kong et al. in their GWAS 
of recombination 33, with annotation in parentheses (below the double line). 
 
2.5.1.1 Candidate Genes Associated with Chromosome Segregation 
These genes are shown in the top half (above the double line) of Table 2.2. Examination 
of genes involved in the meiotic cohesion complex showed a statistically significant association 
with RAD21L, a meiosis-specific member of the α-kleisin protein family [50-53]. This was 
significant in both the mothers vs. fathers and the MI mothers vs. fathers comparisons, and has a 
similar effect (odds ratio) in the MII cases at the same SNP (Figure 2.1). Meiotic cohesins are 
essential for sister chromatid cohesion, but also have an effect on other prophase I processes, 
including formation of the axial/lateral elements, assembly of the SC, and crossing-over (e.g., [54, 
55]). Gene disruption of RAD21L leads to sexually dimorphic phenotypes in mice. Male mice are 
infertile, whereas female mice show age-related infertility, reminiscent of primary ovarian 
 33 
insufficiency. The reduced efficiency in synapsis in fetal oocytes may result in a lower ovarian 
reserve to be established [53] In human males, variants in RAD21L have been implicated in 
meiotic arrest and Sertoli cell-only syndrome [56]. 
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Figure 2.1 LocusZoom plot for RAD21L 
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Variants in seven genes coding for components of the SC were also investigated in this 
candidate gene group. Of the genes coding for components of the central element of the SC (i.e., 
SYCE1, SYCE2, SYCE3, TEX12), SYCE2 showed a statistically significant association (in the MI 
mothers vs. fathers) (Figure 2.2), although the association with SYCE3 was close to the cutoff for 
significance (also in MI mothers vs. fathers). 
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Figure 2.2 LocusZoom plot for SYCE2 
The other SC genes we examined code for the transverse filament (SYCP1) and 
components of the axial/lateral elements (SYCP2 and SYCP3). SYCP1 showed significant 
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association in the MI vs. MII analysis, but not in the other analyses (Figure 2.3). The signal in 
SYCP1 was primarily located at an imputed SNP, at rs35401563, so this result requires 
confirmation by further genotyping. SYCP2 showed highly significant associations in both the MII 
mothers vs. fathers and the MI vs. MII comparisons (Figure 2.4), suggesting the potential for an 
effect specific to MII. SYCP3 was nearly significant in the MI vs. MII comparison.  
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Figure 2.3 LocusZoom plot for SYCP1 
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Figure 2.4 LocusZoom plot for SYCP2 
Among the other candidate genes in this group, the only statistically significant result was 
for MND1. The observed significant association was strongest in the MI vs. MII comparison, was 
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also strong in the MII vs. fathers comparison, and was much weaker in the MI vs. fathers 
comparison. This pattern suggests that this locus may be associated with MII nondisjunction. 
Based on genetic and cellular analysis of deletion mutants, MND1, acting with HOP2, plays a role 
in the initial processing of DSBs. Specifically, the HOP2-MND1 complex is involved in two 
separate stages of the DMC1-promoted recombination process: first, in the stabilization of DMC1 
filaments on the resected end of the DSBs, and second, in the promotion of the subsequent strand 
invasion steps. In higher eukaryotes (mouse [57] and Arabidopsis thaliana [58, 59]), MND1 
appears to be required for normal male and female fertility. Mutations result in normal 
recombination initiation, but meiotic DSBs are abnormally repaired and chromosome synapsis is 
aberrant [29]. The HOP2-MND1 complex has also been implicated in ovarian dysfunction and 
biochemically, is capable of driving RAD51-mediated alternative lengthening of telomeres in 
somatic cells [60]. If this association is confirmed, understanding why the effect of the variant is 
stronger in MII errors vs. MI errors may shed more light on its function.  
2.5.1.2 Genes Association with Human Genome-Wide Recombination Counts (Shown in 
the Bottom Half of Table 2.2, Below the Double Line) 
We also examined the eight regions identified in Kong et al. that were highly associated 
with genome-wide recombination counts in a large Icelandic study of 71,929 parent-offspring pairs 
[15]. Of the eight regions, three showed associations with maternal nondisjunction that were 
statistically significant according to the cutoffs shown in Table 2.2. The first region included 
RAD21L for which results are discussed above, as it was also in the group of candidate genes for 
meiotic processes. The second statistical signal was in the region of SMEK1 (also known as protein 
phosphatase 4 regulatory subunit 3 (PPP4R3A)) and was strongest in the MI vs. MII mothers 
comparison (Figure 2.5). SMEK1 is known as a regulator of cellular functions, including 
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apoptosis, cell growth, microtubule organization, cell cycle arrest, and TNF and PI3K/Akt 
signaling (e.g., [61, 62]). It is also known to play a role in endothelial cell function and subsequent 
angiogenesis [63]. However, its role in meiosis is unknown, although it is known to be expressed 
in the ovary. 
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Figure 2.5 LocusZoom plot for SMEK1 
The third signal is in the region of CCDC43, and was evident in both the MI mothers vs. 
fathers analysis and the MII mothers vs. fathers analysis (see S7 Figure). There is no known 
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function of CCDC43 in meiosis. In the study of Kong et al. [15], the SNP associated with 
recombination (rs75502650) was located in an intron of CCDC43. It was estimated to increase the 
global recombination rate by 76 cM and this effect was limited to females.  
2.5.2 Strongest Results from the Genome-Wide Association Study 
Because of the limited sample size in this study, the full GWAS produced only suggestive 
results, though a few of those top results have strong support in the literature for the relevance of 
the gene functions to meiosis or fetal survival. Manhattan plots and Q-Q plots for each GWAS 
analysis are included in the Supporting Information (S10 Figure). Tables 2.3-2.7 show the most 
statistically significant results from each of the comparisons in the genome-wide association study. 
For each result for a given comparison, the corresponding table also gives the smallest p-value 
within 20kb in each of the other comparisons. Detailed results are included in the Supporting 
Information (S3-S7 Tables). 















rs10948101 P=7.65e-07 P=1.58e-06 P=0.000897 P=0.0634 P=0.00514 
rs35141718 P=2.02e-06 P=1.92e-05 P=0.0109 P=0.127 P=0.0499 
rs11535058 P=2.42e-06 P=2.1e-05 P=7.69e-05 P=0.0411 P=0.015 
rs62086686 P=4.45e-06 P=0.000292 P=8.53e-05 P=0.0171 P=0.0133 
rs75733466 P=5.09e-06 P=0.00023 P=1.24e-05 P=0.00189 P=0.0212 
rs117746305 P=5.14e-06 P=0.000168 P=3.93e-06 P=0.056 P=0.0881 
rs12947774 P=5.62e-06 P=0.000199 P=0.000949 P=0.00229 P=0.0339 
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rs1612273 P=5.93e-06 P=7.22e-05 P=1.62e-05 P=0.000934 P=0.00432 
rs12652455 P=6.43e-06 P=2.43e-05 P=0.000437 P=0.0429 P=0.0518 
rs148846406 P=6.79e-06 P=3.85e-05 P=0.00673 P=0.0562 P=0.00883 
rs11026040 P=8.22e-06 P=0.000238 P=3.1e-05 P=0.00505 P=0.00794 
rs7010571 P=8.27e-06 P=3.41e-05 P=0.0185 P=0.0796 P=0.0477 
rs35816728 P=9.96e-06 P=6.09e-05 P=0.00101 P=0.00124 P=0.00815 
Suggestive associations (p < 10-5) are recorded (highlighted cells). For each such locus, the most significant 
association within 20kb is recorded for each of the other four genome-wide analyses. Rows are ordered by 
significance.  (MI: meiosis I; MII: meiosis II; P: p-value.) 
 















rs10948100 P=7.65e-07 P=1.58e-06 P=0.000897 P=0.0634 P=0.00514 
rs35288347 P=1.26e-05 P=2.72e-06 P=0.023 P=0.0298 P=0.0339 
rs4649043 P=0.000148 P=3.1e-06 P=0.00388 P=0.000408 P=0.00556 
rs437933 P=1.79e-05 P=3.29e-06 P=0.0683 P=0.05 P=0.0186 
rs16847735 P=2.44e-05 P=3.77e-06 P=0.0173 P=0.0135 P=0.0617 
rs2467011 P=5.02e-05 P=4.29e-06 P=0.0902 P=0.00786 P=0.158 
rs9442389 P=1.88e-05 P=5.27e-06 P=0.0701 P=0.0164 P=0.0241 
rs731245 P=0.000148 P=6.91e-06 P=0.00772 P=0.000809 P=0.00654 
rs984968 P=1.48e-05 P=6.95e-06 P=0.0741 P=0.0425 P=0.0833 
rs9984132 P=5.86e-05 P=9.87e-06 P=0.0539 P=0.00662 NA 
Suggestive associations (p < 10-5) are recorded (highlighted cells). For each such locus, the most significant 
association within 20kb is recorded for each of the other four genome-wide analyses. Rows are ordered by 
significance.  (MI: meiosis I; MII: meiosis II; P: p-value.) 
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rs1855111 P=6.48e-05 P=0.00213 P=2.2e-06 P=0.00698 P=0.00494 
rs76740710 P=7.19e-06 P=0.000236 P=3.93e-06 P=0.0341 P=0.00648 
rs12981234 P=0.0013 P=0.00911 P=4.28e-06 P=8.8e-05 P=0.0854 
rs200216460 P=0.000209 P=0.0104 P=4.99e-06 P=0.00373 P=0.00284 
rs11668205 P=0.00588 P=0.00218 P=5.49e-06 P=3.34e-05 P=0.0233 
rs146838878 P=0.0197 P=0.0249 P=6.16e-06 P=0.000328 P=0.000463 
rs115281615 P=0.047 P=0.0792 P=6.34e-06 P=7.33e-07 P=0.0712 
rs62359711 P=0.0024 P=0.00108 P=6.91e-06 P=0.000191 P=0.0112 
rs73178888 P=0.00754 P=0.0041 P=7.05e-06 P=1.72e-05 P=0.0122 
rs9966603 P=0.00967 P=0.0639 P=7.05e-06 P=0.00208 P=0.00759 
rs13020106 P=0.00149 P=0.0335 P=7.12e-06 P=0.00336 P=0.0162 
rs2560850 P=0.0016 P=0.00365 P=7.69e-06 P=0.000332 P=0.00604 
rs1191234 P=0.00176 P=0.0137 P=9.98e-06 P=0.00157 P=0.0411 
Suggestive associations (p < 10-5) are recorded (highlighted cells). For each such locus, the most significant 
association within 20kb is recorded for each of the other four genome-wide analyses. Rows are ordered by 
significance.  (MI: meiosis I; MII: meiosis II; P: p-value.) 
 















rs115281615 P=0.047 P=0.0792 P=6.34e-06 P=7.33e-07 P=0.0712 
rs6440985 P=0.0958 P=0.0112 P=0.000198 P=1.31e-06 P=0.00796 
rs2806747 P=0.0934 P=0.0656 P=0.00037 P=1.35e-06 P=0.00284 
rs9319652 P=0.0225 P=0.0267 P=0.00243 P=4.09e-06 P=0.039 
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rs11977478 P=0.00474 P=0.00902 P=0.00019 P=4.18e-06 P=0.00232 
rs11034351 P=0.0124 P=0.00284 P=7e-04 P=4.3e-06 P=0.0295 
rs7685548 P=0.00618 P=0.000955 P=0.00884 P=4.82e-06 P=0.00226 
rs71967233 P=0.044 P=0.0785 P=0.000135 P=5.24e-06 P=0.0163 
rs34282937 P=0.0334 P=0.0368 P=5.95e-05 P=5.48e-06 P=0.0298 
rs77525287 P=0.0707 P=0.000444 P=0.0124 P=5.9e-06 P=0.099 
rs4818884 P=0.0454 P=0.0312 P=0.00354 P=9.57e-06 NA 
rs61999085 P=0.00851 P=0.000125 P=0.0449 P=9.84e-06 P=0.00243 
Suggestive associations (p < 10-5) are recorded (highlighted cells). For each such locus, the most significant 
association within 20kb is recorded for each of the other four genome-wide analyses. Rows are ordered by 
significance.  (MI: meiosis I; MII: meiosis II; P: p-value.) 
 















rs3802065 P=0.0144 P=0.0066 P=0.0318 P=0.00859 P=4.84e-07 
rs2867076 P=0.0164 P=0.0227 P=0.008 P=0.00904 P=1.05e-06 
rs7451700 P=0.0186 P=0.0169 P=0.054 P=0.0195 P=1.71e-06 
rs7389783 P=0.0421 P=0.0397 P=0.0048 P=0.00741 P=1.93e-06 
rs17769147 P=0.182 P=0.152 P=0.0738 P=0.0624 P=2.06e-06 
rs201634098 P=0.00592 P=0.00385 P=0.0722 P=0.015 P=3.52e-06 
chr23:154539980 NA NA NA NA P=3.63e-06 
rs74615884 P=0.0801 P=0.037 P=0.0167 P=0.00236 P=3.73e-06 
rs158866 P=0.036 P=0.00582 P=0.0103 P=0.0102 P=3.77e-06 
rs1187600 P=0.0553 P=0.0636 P=0.204 P=0.156 P=6.25e-06 
rs55743346 P=0.0514 P=0.0371 P=0.0834 P=0.0234 P=7.34e-06 
rs183199067 P=0.0131 P=0.00285 P=0.0396 P=0.0254 P=9.55e-06 
rs140022090 P=0.0163 P=0.00733 P=0.0538 P=0.00493 P=9.55e-06 
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rs34518363 P=0.00538 P=0.00186 P=0.049 P=0.0394 P=9.55e-06 
rs6681167 P=0.0358 P=0.0505 P=0.0648 P=0.0377 P=9.58e-06 
Suggestive associations (p < 10-5) are recorded (highlighted cells). For each such locus, the most significant 
association within 20kb is recorded for each of the other four genome-wide analyses. Rows are ordered by 
significance.  (MI: meiosis I; MII: meiosis II; P: p-value.) 
2.5.2.1 rs10948101 on chromosome 6 near VEGFA 
The observed signal for this locus was strongest for the analysis of all mothers vs. fathers 
and was located within LOC100132354, a long non-coding RNA (lncRNA) (Figure 2.6). Upstream 
of this intergenic lncRNA is VEGFA, the gene encoding vascular endothelial growth factor A 
(VEGFA). In a recent meta-analysis, LOC100132354 was confirmed to be highly associated with 
VEGF circulating levels in serum [64]. VEGFA plays multiple roles in ovarian development and 
function (reviewed in McFee and Cupp [65]). Vascularization plays a role in the formation of early 
ovarian structures, primordial follicle assembly, and follicle activation. Further, ovarian function 
is highly dependent on the development and continual remodelling of a complex vascular system. 
This allows the follicle and the corpus luteum to receive the needed oxygen, nutrients, and systemic 
hormones and the release of ovarian hormones (reviewed in Robinson et al. [66]). If angiogenesis 
is disrupted, follicular growth is reduced, ovulation is perturbed, and development and function of 
the corpus luteum is significantly altered. The action of VEGFA is necessary at all these stages of 
development. We did not see any significant effect in the TDT analysis, so there is no suggestion 
that this locus is associated with survival to term. 
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Figure 2.6 LocusZoom plot for VEGFA locus 
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2.5.2.2 rs11535058 on chromosome 2 near SLC39A10 
The observed signal in this region, strongest in the mothers vs. fathers comparison, was 
located 132kb downstream of SLC39A10 (Figure 2.7), with a similar, but non-significant, effect 
size for both MI mothers vs. fathers and MII mothers vs. fathers. SLC39A10 is involved in the zinc 
transport network. Regulation of intracellular zinc is essential for oocyte maturation and activation. 
In mouse, progression of the oocyte from a cell arrested in prophase of MI into a mature egg 
arrested at metaphase of MII is accompanied by an increase in total zinc content. This increase is 
required for proper meiotic progression [67]. Also, exit from MII during oocyte activation requires 
decreasing cellular zinc through the rapid export of zinc from the oocyte. These ‘zinc sparks’ are 
required for oocyte activation and resumption of the cell cycle [68].  
Specific to SLC39A10, Lisle et al. [69] found a complex zinc transport network present in 
the cumulus-oocyte complex in mouse oocytes. They found that mRNA transcripts for specific 
zinc transporter proteins (SLC family), including Slc39a10 were higher in oocytes, while another 
unique set of zinc transporter protein transcripts were higher in cumulus cells. Thus, zinc 
homeostasis, regulated in the cumulus-oocyte complex, may affect both MI and MII processes. 
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Figure 2.7 LocusZoom plot for SLC39A10 locus 
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2.5.2.3 rs35288347 on chromosome 19 near AURKC 
This signal occurs primarily in the MI mothers vs. fathers analysis (Figure 2.8), with a 
similar but less significant effect in the mothers vs. fathers analysis. Consistent with the possibility 
of an effect specific to MI, mutations in the AURKC gene in this region (160kb away) cause 
tetraploidy in human sperm and MI arrest in mouse oocytes [70, 71]. 
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Figure 2.8 LocusZoom plot for AURKC locus 
 53 
2.5.2.4 rs9984132 on chromosome 21 located in a gene rich region 
The signal at rs9984132 on chromosome 21 is located in a gene-rich region (Figure 2.9). 
The strongest signal at this locus was identified in the comparison of MI mothers with fathers. 
Two genes stand out as possible candidates for involvement in chromosome segregation. COL6A2, 
located 34kb upstream of the signal, codes for one of the components of collagen that is part of 
the extracellular matrix (ECM) formed by cumulus cells. This ovarian follicular ECM is related to 
proliferation, steroidogenesis, and luteinization [72]. As the formation of this ECM is involved in 
fertilization and embryo quality, the observation that this signal appears to be only related to MI 
nondisjunction reduces the support of COL6A2 as a candidate. 
PCNT is a gene located about 260kb upstream from the signal. Pericentrin, coded by PCNT, 
is a highly conserved component of the acentriolar microtubule-organizing centers (aMTOCs) in 
mouse oocytes. aMTOCs play a vital role in meiotic spindle assembly and stability. Depletion of 
pericentrin in mouse oocytes leads to increased rates of aneuploidy [73]. Human oocytes differ 
from mouse oocytes in that they lack PNCT and aMTOCs in MI, where spindle assembly is 
mediated from chromosomes by the small guanosine triphosphates [74]. Thus, more work is 
needed to confirm this signal and its underlying genetic association.  
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Figure 2.9 LocusZoom plot for rs9984132 locus 
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2.5.2.5 rs73178888 on chromosome 8 near a region associated with meiotic recombination 
This signal, located in an intron of ERICH1, is primarily observed in the MII mothers vs. 
fathers analysis and in the MI vs. MII analysis, suggesting that it might be an MII risk locus (Figure 
2.10). The location is noteworthy because Begum et al. [75] identified a variant 59kb away in this 
region as potentially associated with meiotic recombination (specifically recombination outside of 
hotspots) in a euploid population. There is no evidence to suggest that ERICH1 or DLGAP2 (also 
known as ERICH1-AS1), 3kb from the signal, is involved in recombination or meiosis. The next 
closest gene is TDRP. The deficiency of TDRP in mice is suggested to be involved in sperm 




Figure 2.10 LocusZoom plot for DLGAP2 locus 
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2.5.2.6 rs115281615 on chromosome 4 near CPEB2 
The signal at this locus is primarily observed in the MII mothers vs. fathers comparison 
(Figure 2.11). The genes in the region, C1QTNF7, and CC2D2A, do not have evidence for a role 
in meiosis. CPEB2, located 193kb from the signal, encodes an RNA-binding protein, cytoplasmic 
polyadenylation element binding protein and is thought to be involved in regulated translation, a 
system that allows the rapid production of selective proteins in response to a physiological signal. 
CPEB2 interacts with the elongation factor, eEF2, to slow down peptide elongation of CPEB2-
bound RNA [77]. In mice, this protein is highly similar to the family of CPEBs that regulate 
cytoplasmic polyadenylation of mRNA as a trans-factor in oogenesis and spermatogenesis. CPEB2 
is expressed post-meiotically in mouse spermatogenesis, which suggests a possible role in 
translational regulation of stored mRNAs in transcriptionally inactive haploid spermatids [78]. 
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Figure 2.11 LocusZoom plot for CPEB2 locus 
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2.5.2.7 rs2560850 on chromosome 5 in an intron of MYO10 
The comparison between MII mothers vs. fathers shows the strongest statistical 
significance for this locus which includes MYO10 (Figure 2.12). Myosin-10 proteins are 
phosphoinositide-binding, actin-based motors that play an important role during meiosis in the 
integration of the F-actin and microtubule cytoskeletons. Proper spindle positioning and 
orientation are essential for asymmetric cell division and these functions are particularly important 
in meiosis. In Xenopus oocytes, Weber et al. [79] showed that myosin-10 is associated with 
microtubules and is concentrated where the meiotic spindle contacts the F-actin-rich cortex. This 
observation and others suggest that myosin-10, the microtubule-binding myosin, is required for 
anchoring the spindle and an actin-binding kinesin is required for meiotic cytokinesis [79, 80]. 
Recently F-actin was shown to permeate the microtubule spindles in oocytes of many mammals, 
including human, where it prevents lagging chromosomes and thus segregation errors, including 
during anaphase I [81]. 
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Figure 2.12 LocusZoom plot for MYO10 locus 
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2.5.3 Strongest Results from the TDT Analyses 
Together with the other case/control association tests to identify genes associated with 
nondisjunction, we also had the opportunity to use the TDT. We assumed that the TDT might help 
tease apart genes associated with nondisjunction from those associated with fetal “survival genes.” 
If there is association between maternal genotype and either nondisjunction or survival, this test 
can theoretically identify it. We only performed this test in our GWAS approach, not our candidate 
genes, since the candidates were chosen for possible involvement in nondisjunction per se. Here 
we highlight two genes where the statistical signal was relatively strong, although not genome-
wide significant.  
The first is located at rs17769147, 24kb upstream of the gene RNF182, which encodes a 
RING-finger-containing transmembrane protein that includes an E3 ubiquitin ligase activity. 
There was no statistical signal for any of the case/control comparisons, only for the TDT. Studies 
have shown that this gene is expressed preferentially in the brain and is up-regulated in 
Alzheimer’s disease brain and in neuronal cell cultures that are subject to stress-induced cell death 
[82]. In another line of study, RNF182 was found to be one of the gene targets of MeCP2, the gene 
involved in Rett syndrome. The group of identified gene targets are involved in the regulation of 
the cell growth and survival of neuronal cells [83].  
Another strong TDT signal was found at rs158866, with no statistical signal for any of the 
case/control comparisons. This signal is located within NEDD4L (also referred to as NEDD4-2), a 
gene encoding a ubiquitin ligase. This protein binds and regulates membrane-associated proteins 
(although not exclusively), particularly ion channels and transporters (reviewed in Goel et al. [84]). 
NEDD4L interacts with several other proteins and may regulate other important substrates as well 
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(e.g., [85, 86]). Based on current evidence, this ligase is essential for the maintenance of cellular 
homeostasis. 
2.6 DISCUSSION 
We present, for the first time, a candidate gene study and GWAS of chromosome 21 
maternal nondisjunction. The goal of this project was to gain insight into factors that may 
predispose a woman to this common chromosomal error.  
2.6.1 Genes Associated with Cohesin Complex 
The meiosis-specific cohesin subunits are encoded by SMC1β, REC8, RAD21L, and 
STAG3. Of these genes, we found that variation in RAD21L was associated with nondisjunction, 
with the strongest signal with MI nondisjunction. As part of the cohesion complex [50-53], 
RAD21L plays a role in the structural maintenance of chromosomes (SMC) complex. The SMC 
complex includes cohesin, condensin and SMC5/6, and is an important regulator of chromosome 
dynamics and structure during both mitosis and meiosis. In female mice, mutations in meiosis-
specific cohesins and in the SMC complex increase the frequency of oocyte aneuploidy and 
primary ovarian insufficiency [53, 87-89]. The study of Kong et al. [15] found a highly significant 
association of RAD21L with male recombination and a much weaker signal in females; Begum et 
al. [75] did not replicate this finding, although the genomic region had poor coverage in two of the 
three datasets of their study. Together, this suggests a sex-specific role of RAD21L and one in 
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females that maybe more directly related to segregation of bivalents than recombination counts 
per se. 
There are several possible explanations for why genetic variation in RAD21L was 
associated with maternal nondisjunction whereas variation in REC8 was not, although both are α-
kleisin subunits that are part of the cohesin complex. One possible explanation is that there is 
reduced power to detect a signal based on allele frequencies of variants in REC8 compared with 
RAD21L. Alternatively one gene may play a more essential role in meiosis, where variation is not 
tolerated or not compatible with the oocyte surviving to fertilization. It is known that these genes 
play unique roles during meiosis and thus have differential effects on the meiotic process [90-92]. 
2.6.2 Genes Associated with the Synaptonemal Complex (SC) 
The general structure of the SC is highly conserved across yeast and mammals, although 
the genes and proteins involved are not always conserved (reviewed in Cahoon and Hawley [22]). 
The tripartite protein structure extends along the entire length of the synapsed homologues and 
assembles alongside cohesin and cohesin-like proteins that hold the sister chromatids of the 
homologues together (e.g., [93, 94]). Mutations in genes coding for SC components have been 
identified previously among women with infertility or recurrent miscarriages (reviewed in 
Geisinger and Benavente [95]). At this time, only mutations in SYCP3 and SYCE1 have been 
identified, but most studies had <100 women available for study. In our study, we found evidence 
for an association of variants in genes of all three SC components with maternal nondisjunction. 
We had supporting evidence for SYCP3 (although not statistically significant), with the strongest 
statistical signal being found in the comparison of MI vs. MII. In addition, we found a statistically 
significant association of SYCE2 in MI vs. fathers and with SYCP2 in the comparison of MI vs. 
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MII. Thus, with an increased sample size and a more homogeneous reproductive outcome, we 
were able to confirm the importance of the SC structure for proper segregation of chromosome 
during human oogenesis. 
2.6.3 Association with Recombination-Related Variants 
It is now well established that there is both significant sex-specific and individual variation 
in genome-wide recombination counts and location of events, in spite of the need for the 
recombination process to be tightly controlled [96-98]. When there are alterations in the number 
of recombinants (reduced or no recombination) or their location (pericentromeric or telomeric), 
there is a high risk for human chromosome nondisjunction [99-101]. Variation in genes that play 
a role in recombination has been identified and we examined those that were identified in a large 
Icelandic study using linkage analyses of live births [15]. Begum et al. [75] also attempted to 
replicate the association of these variants in a population of primarily Northern European ancestry. 
Their GWAS meta-analyses were extended to the study of recombination phenotypes, including 
the average recombination count along with those related to placement relative to historical 
recombination hotspots. Here, we asked whether these variants would also explain susceptibility 
to maternal nondisjunction. Our results are interesting both with respect the identification of 
associated regions and to the lack of evidence in the others.  
Both Kong et al. [15] and Begum et al. [75] found a strong association of SMEK1 (also 
known as PPP4R3A) with recombination in females only. Our results identified the strongest 
association in the comparison of MI vs. MII nondisjunction, which suggests a stage-specific role 
of this protein, as well as a sex-specific role identified in the recombination studies. At this time, 
there is no known role of SMEK1 in meiosis. It is a member of the PP2A subfamily. PP2A is 
 65 
involved in de-protection of centromere cohesin in MII of mammals, a process that is essential for 
proper sister chromatid segregation (reviewed in Wassmann [102]). Although it is intriguing to 
think that variation in SMEK1 may alter this MII-associated process, this is no direct link at this 
time. 
Another locus that deserves follow-up is on chromosome 8 near rs73178888, one of the 
top hits in our genome-wide analyses. Begum et al. [75] identified this same region as potentially 
associated with meiotic recombination in a euploid population. Although the genes in the region 
do not appear to be linked to recombination, further investigation is warranted. 
With respect to the two most well-established genes associated with recombination, 
RNF212 and PRDM9, our data showed no association with nondisjunction. Variation in RNF212 
is sex-specific, some variants being associated with increased recombination in males and others 
in females [15, 75, 98, 103-105]. RNF212 is known to form many discrete foci along chromosomes 
early in meiotic prophase I; these foci are then reduced to a few sites where crossovers are formed 
[106]. For small chromosomes such as chromosome 21, perhaps female-specific variation in this 
process is less evident compared with genome-wide alterations.  
Variation in PRDM9 is known to be associated with recombination hotspots in both males 
and females. Kong et al. [15] showed that variants were also associated with total recombination 
counts in males, but not females. Begum et al. [75] provided further evidence that in females, 
variants were associated with both recombinant counts within and outside of historical hotspots, 
in opposite directions. They suggested that females might have a compensatory mechanism, such 
that increased recombination in hotspots is balanced by decreased recombination elsewhere; 
thereby not altering the overall recombination count. In males, variants were only associated with 
recombinants within historical hotspots. In our previous study, we found that historical hotspot 
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usage along maternally-derived nondisjoined chromosomes 21 was similar to that in controls, 
particularly among MI errors, indicating that the observed altered telomeric placement probably 
does not involve differential hotspot usage [12]. Subsequently, Oliver et al. [107] studied sequence 
variation in the zinc finger-binding domain (ZFBD) of PRDM9 in a subset of the study sample 
presented here. They found that the frequency of the PRDM9 ZFBD minor alleles was significantly 
increased among women who had a chromosome 21 nondisjunction event and no observed 
recombination on 21q. Further, when these PRDM9 minor alleles were compared with the major 
A-allele, fewer predicted binding sites on 21q were found. Together, these observations suggest 
that allelic variation in PRDM9 may play a role in nondisjunction, but that the effect size may be 
small and it may be limited to nondisjunction of achiasmate chromosomes. 
2.6.4 Gene Discovery 
When we conducted a GWAS, no variants were genome-wide significant; thus, the 
marginally significant signals need replication prior to additional speculation. We highlighted a 
few findings in Results for signals in genes that are known to be involved in oogenesis. If these 
are true signals, our data are consistent with the idea that the underlying susceptibility for 
chromosome nondisjunction involves different components of oogenesis.  
2.6.5 Conclusion and Future Directions 
Our candidate gene study was successful in detecting statistically significant associations 
of maternal nondisjunction of chromosome 21 and variation in genes that are essential for proper 
chromosome segregation during meiosis. Future studies are needed to investigate other known risk 
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factors and their interaction with the genetic variation. For example, stratification by maternal age 
at the time of birth of the infant with trisomy 21 could provide insight into mechanism of the 
identified genetic variants. In our exploratory analyses, we did not observe unique age-associated 
variants; however, our sample sizes were limited. Thus, expansion of the study sample with 
enrichment of the youngest and oldest maternal age groups would be valuable. Also, studies that 
further stratify meiotic errors by recombination risk patterns known to increase susceptibility of 
nondisjunction, namely lack of observed recombination, a single telomeric recombination event 
or a pericentromeric event, may provide further insight into the function of the genetic variant. 
Another possible approach is to examine other sources of samples from which information 
on aneuploidy may be drawn to obtain larger sample sizes. For example McCoy et al. [108] studied 
day-3 embryos obtained from in vitro fertilization cycles and parents to identify both meiotic and 
mitotic segregation errors. Irrespective, we have begun to gain insight into which meiotic proteins 
may be more susceptible to genetic variation, leading to abnormal chromosome segregation. 
Independent studies are needed to replicate findings from our GWAS study to further identify 
novel susceptibility genes. 
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3.0 ANALYSES STRATIFIED BY MATERNAL AGE AND RECOMBINATION 
FURTHER CHARACTERIZE GENES ASSOCIATED WITH MATERNAL 
NONDISJUNCTION OF CHROMOSOME 21 
This chapter has been published in Prenatal Diagnosis. The article is reproduced here under 
license from Wiley with only minor formatting and non-scientific changes. The original article 
and supporting information are available online at https://doi.org/10.1002/pd.5919. 
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3.1 CHAPTER OVERVIEW 
Objective: In our previous work, we performed the first genome-wide association study to 
find genetic risk factors for maternal nondisjunction of chromosome 21. The objective of the 
current work was to perform stratified analyses of the same dataset to further elucidate potential 
mechanisms of genetic risk factors. 
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Methods: We focused on loci that were statistically significantly associated with maternal 
nondisjunction based on this same dataset in our previous study and performed stratified 
association analyses in seven subgroups defined by age and meiotic recombination profile. In each 
analysis, we contrasted a different subgroup of mothers with the same set of fathers, the mothers 
serving as cases (phenotype: meiotic nondisjunction of chromosome 21) and the fathers as 
controls. 
Results: Our stratified analyses identified several genes whose patterns of association are 
consistent with generalized effects across groups, as well as other genes that are consistent with 
specific effects in certain groups.  
Conclusions: While our results are epidemiological in nature and cannot conclusively 
prove mechanisms, we identified a number of patterns that are consistent with specific 
mechanisms. In many cases those mechanisms are strongly supported by available literature on 
the associated genes. 
3.2 INTRODUCTION 
At least 5% and possibly as many as 20% of human conceptions are aneuploid as a result 
of errors in meiosis, and the vast majority of these errors occur in maternal meiosis I, which begins 
in oocytes during fetal development and is arrested in prophase I for years until resumption in 
adulthood [1-5, 109]. The decades-long timespan for female meiosis and the different timescales 
and processes involved in completion of meiosis I and meiosis II make maternal age a critical risk 
factor for nondisjunction but also make each stage susceptible to different error mechanisms [6, 
109]. In addition to maternal age, altered patterns of meiotic recombination are also associated 
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with nondisjunction [8-14]. As one of the few aneuploid conditions with which humans survive to 
term, trisomy 21 provides crucial insight into human meiotic nondisjunction [5-7, 20].  
In our previous work, we performed the first genome-wide association study to find genetic 
risk factors for maternal nondisjunction of chromosome 21 [18]. There we contrasted groups of 
mothers of live-born children with standard trisomy 21 derived from maternal nondisjunction with 
fathers (a convenient control group). Because earlier research suggested that maternal meiosis I 
(MI) and meiosis II (MII) nondisjunction of chromosome 21 may have some unique etiological 
factors and some factors in common, we stratified mothers by meiotic stage of error in order to 
clarify how genetic risk factors contribute to nondisjunction in each stage. In addition to the 
genome-wide analyses, we also investigated candidate genes and loci known to be involved with 
meiotic processes or associated with global recombination counts in humans. We observed a 
number of interesting associations with loci plausibly involved in maternal meiotic nondisjunction. 
In this study we extend our earlier work by performing further stratified analyses of the 
same dataset in order to dissect the genetic associations we found with MI and MII errors. These 
analyses will help explore whether the MI/MII classification masks heterogeneity in maternal 
meiotic nondisjunction and may suggest how genes contribute to particular nondisjunction 
mechanisms. For example, stratifying by maternal age can clarify whether younger mothers have 
a higher genetic risk burden than older mothers (or different risk factors altogether). Similarly, 
within MI and MII errors, different genes may contribute to the recombination profiles on 
chromosome 21 associated with nondisjunction in each stage. These stratifications may also 
provide a glimpse into how genes contribute to nonstandard mechanisms such as premature 
separation of sister chromatids (PSSC) and reverse segregation (RS). Because this further 
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stratification reduces sample sizes, we performed these stratified analyses in a hypothesis-driven 
manner, only examining genes and loci that have strong prior support based on the previous work. 
3.3 METHODS 
3.3.1 Study Participants and Ethics Statement 
3.3.1.1 Participants 
The participants of our study were 749 individuals with non-translocation, maternally-
derived trisomy 21 and their 1,437 available biological parents. Self-reported race/ancestry was 
72% white, 4% Hispanic, 2% African/African-American or Asian, and 23% other or unknown 
descent. Participants were recruited in the United States through a birth surveillance system for 
Down syndrome and later through convenience sampling [7] (see also [18]). 
3.3.1.2 Ethics Statement 
At each site an IRB approved the study protocol, consent forms, and data sharing. At Emory 
University, the data and biological sample repository, the IRB approved sample processing and 
submission to the Center for Inherited Disease Research for genotyping (Emory School of 
Medicine IRB number IRB00005100). Study data were uploaded to dbGaP (phs000718) with IRB 
approval. 
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3.3.2 Genotyping, Imputation, and Population Structure 
The genotyping, imputation, and investigation of population structure for this study group 
have been described in our previous study [18]. Briefly, genotypes were assayed with the Illumina 
HumanOmniExpressExome-8v1-2 array and initially processed at the Center for Inherited Disease 
Research. Genotypes for 2,186 unique participants were released to the University of Washington 
Genetic Coordinating Center for quality assurance/control and imputation. QA/QC for GWAS 
followed standard procedures described by Laurie et al. [38], and imputation to the 1000 Genomes 
Project’s Phase I reference panel [44] was performed with IMPUTE2 [43]. Trisomic SNP 
genotypes on chromosome 21 were called from the array data using previously described methods 
[17]. In addition to these SNP genotypes, STR genotypes from an earlier phase of the study were 
available on chromosome 21 and were used in a few cases to determine the meiotic stage of 
trisomy, as described below. Principal components of ancestry were calculated to adjust for 
population structure; the first three were used as covariates in all regression analyses below. 
Detailed reports on QA/QC, population structure, and imputation are available through dbGaP 
(phs000718). 
Trisomy (full or mosaic) was confirmed by karyotype in nearly all 749 individuals with 
Down syndrome, but in a few cases a birth record or parent report was used. Trisomic genotype 
cluster plots were visually inspected for all 12,982 chromosome 21 SNPs; 3,853 SNPs subjectively 
regarded as showing poor clustering or showing small minimum cluster sizes were excluded from 
analysis. As a further quality control step, we compared parental and child SNP genotypes on 
chromosome 21 to confirm consistency with maternal origin of the trisomy. In 16 instances, the 
SNP genotypes were not broadly consistent with maternal origin. Most of these cases were 
traceable to mosaic trisomies or other anomalies identified by karyotyping, but we excluded these 
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families from downstream analyses, which required broadly reliable genotypes in the children. In 
7 instances neither parent was genotyped. In all, 615 parent-child trios and 94 mother-child dyads 
were available for calling recombination events. 
3.3.3 Determining Meiotic Stage of Error and Recombination on Chromosome 21 
The primary analyses in this study were centered on mothers who had had a nondisjunction 
event resulting in live birth of a child with full or mosaic trisomy 21. Subgroups of maternal errors 
were defined by known risk factors: recombination pattern on the nondisjoined chromosome 21 
and maternal age. 
To do this, we used parent and offspring SNP and STR genotypes on chromosome 21 to 
determine stage of meiotic error and to call recombination events on chromosome 21 in each 
family. Because no “gold standard” procedure exists, we developed new methods for calling 
recombination events. These methods are fully described in the Appendix. 
It is important to note that our classification for MI and MII nondisjunction errors is not 
precise, although it has been useful to identify distinct risk factors for maternal age, recombination 
pattern on chromosome 21, and environment [8-14]. The classification is based on whether the 
variants in the pericentromeric q-arm of chromosome 21 contributed by the parent-of-origin of the 
nondisjunction error remain heterozygous or are reduced to homozygosity. The former is deemed 
an “MI error”, as there are representations from both parental homologous chromosomes. The 
latter defines an “MII error”, as only one parental homolog is represented. However, it is now 
evident that there are many paths to each of these groups. Whole chromosome nondisjunction 
clearly leads to an “MI error”, but it is also true that premature (or precocious) separation of sister 
chromatids (PSSC), either at MI or MII, can appear as an MI or MII error, depending on the 
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random segregation of chromatids at each stage; reverse segregation (RS, in which sister 
chromatids from both homologues segregate from each other in MI) can also appear as an MI error, 
or potentially result in euploidy [110, 111]. Further, there is evidence that MII errors are increased 
among oocytes affected by MI errors, potentially complicating the ability to define risk factors 
[112]. Lastly, the U-shaped maternal age curve associated with aneuploidy has been found to be 
the result of the different age-related patterns associated with the underlying mechanisms [113]. 
Specifically, PSSC and reverse segregation significantly increase with maternal age, while the gain 
or loss of a whole chromosome at MI appeared to decrease with the age of the woman. Thus, our 
simplified classification of “MI errors” and “MII errors” will begin to reveal associated genetic 
risk factors, but it is only the first step. 
3.3.4 Association Analyses 
In order to avoid the multiple-testing problems that typically affect subgroup analyses, we 
focused on loci that were statistically significantly associated with maternal MI or MII 
nondisjunction in our previous study of the same dataset, with the goal of further dissecting those 
associations and understanding how they may differ across subgroups. Subgroup differences may 
suggest models of etiology, although such models would require rigorous verification in future 
studies, both statistical and mechanistic. 
In order to understand how genetic associations with maternal nondisjunction of 
chromosome 21 vary across relevant risk subgroups of mothers, we performed stratified 
association analyses in seven subgroups (not all disjoint). In each analysis, we contrasted a 
different subgroup of mothers with the same set of fathers, the mothers serving as cases 
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(phenotype: meiotic nondisjunction of chromosome 21) and the fathers as controls. Table 3.1 
summarizes the association analyses, abbreviations used to refer to them, and the sample sizes. 
Table 3.1 Definition of stratified analysis subgroups and associated sample sizes 
Stratification group (fathers are controls) 
Abbreviation 
Sample size 
(645 fathers) Meiotic stage of error Subgroup 
Meiosis I 0 events MI R0 328 
Meiosis I Single, telomeric event MI telomeric 44 
Meiosis I < 34 years old MI younger 234 
Meiosis I ≥ 34 years old MI older 297 
Meiosis II At least 1 centromeric event MII centromeric 44 
Meiosis II < 34 years old MII younger 73 
Meiosis II ≥ 34 years old MII older 82 
Recombination events refer here to events observed on chromosome 21. 
 
We first stratified by the meiotic stage in which nondisjunction occurred in the oocyte, MI 
or MII. We excluded 16 cases in which the error was determined to be an MII with no 
recombination events detected, as these may represent mitotic rather than meiotic errors. Then, 
within each error type, we defined subgroups based on maternal age and recombination pattern on 
chromosome 21. Specifically, mothers with MI and MII errors were each divided into younger and 
older subsets using a median maternal age split (the median age, 34 years for both MI and MII 
errors, was included in the older group; see Figure 3.1). 
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Figure 3.1 Distribution of maternal ages by meiotic stage of error 
We also defined strata based on the well-established recombination risk profiles associated 
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those with MI errors with a single event near the telomere (“MI telomeric”), and those with MII 
errors with an event near the centromere (“MII centromeric”). To define telomeric and centromeric 
events, we plotted the distributions of the positions of single MI events and of the most proximal 
MII events. Single MI events were defined to be telomeric if they occurred at a position greater 
than 43Mb. Most-proximal MII events were considered centromeric if they occurred at a position 
less than 17 Mb (see Figure 3.2). 
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Figure 3.2 Distributions of positions of single MI recombination events and most proximal MII events 
observed on chromosome 21 
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For each of these seven subgroups, we tested two sets of loci from our prior analysis of this 
dataset (discussed in detail in [18]). One set of loci consisted of the 48 individual variants that 
were identified as associated with nondisjunction in our earlier GWAS of MI and MII 
nondisjunction. Since our aim in the present study was to explore these pre-recorded associations 
that had previously attained p < 1x10-5 rather than to identify new loci, we did not apply a multiple-
testing correction for the number of single-SNP loci tested. Although these loci were already 
significant in the MI or MII groups as a whole, we did penalize for the number of subgroups, 
conservatively applying a significance threshold of p = 0.05/7 = 7.14x10-3 (this is conservative 
because the subgroups partially overlap). Therefore a subgroup association passing this threshold 
was considered to be evidence that the subgroup helped to “drive” the earlier GWAS association 
in the larger group of mothers with MI or MII errors. Note that in these analyses, it is expected to 
observe nominal significance (p < 0.05) in one or more subgroups for each SNP, and our aim is to 
gain insight by comparing effects across subgroups.  
The other set of loci consisted of 37 regions centered around genes relevant to meiotic 
processes and/or loci associated with global recombination counts in humans [15]. Due to limited 
sample sizes in the subgroups, we confined this study to these previously-nominated loci instead 
of performing a new genome-wide scan. Though only a handful of these candidate loci were 
significant in our previous analysis, we investigated all 37 here in order to uncover possible 
heterogeneous subgroup effects that may have been masked (with the caveat that weaker new 
associations must be interpreted cautiously). Since each candidate locus includes numerous SNPs, 
we used the smallest observed p-value to summarize the association. To adjust for multiple testing 
at candidate loci, we approximated Neff, the effective number of independent SNPs tested at each 
locus and applied a Bonferroni-corrected threshold for significance (0.05/Neff) [49]. For 
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conservatively declaring formal statistical significance, we divided this threshold by the number 
of subgroups (seven) as above. 
All association analyses were performed using logistic regression in R [114] and PLINK 
[115], encoding SNP alleles additively and adjusting for the first 3 principal components of 
ancestry. In addition to QA/QC filtering described above, SNPs with extreme deviation from 
Hardy-Weinberg equilibrium and imputed SNPs with info score < 0.5 were excluded. Imputed 
genotypes called with less than 90% confidence were coded as missing. While all candidate-locus 
SNPs were subjected to a ≥1% MAF filter (calculated separately for each analysis), the set of 48 
GWAS-identified SNPs were not. 
We used forest plots to visualize results for single-SNP analyses and LocusZoom [116] 
plots for candidate regions. We also created two “heatmaps” (Figures 3-4) in order to summarize 
the results across all GWAS and candidate loci. 
3.4 RESULTS 
Our previous study of this dataset performed genome-wide and candidate locus association 
analyses of maternally-derived chromosome 21 nondisjunction. We designed those studies to 
identify and distinguish variants associated with nondisjunction in maternal MI errors, MII errors, 
or all maternal errors. Thus, we performed four tests for candidate genes and for the genome-wide 
scans: mothers with MI errors vs. fathers, mothers with MII errors vs. fathers, all maternal errors 
combined vs. fathers, and, lastly, mothers with MI errors vs. those with MII errors. Here we refined 
our analyses into subgroups to further characterize 37 candidate locus associations and 48 GWAS 
associations resulting from that study. Figures 3.3 and 3.6 summarize the results of our stratified 
 81 
analyses for the candidate and GWAS loci, respectively. Table 3.2 provides a qualitative summary 
of selected results. More detailed results are included in the Supporting Information. Below we 
describe each set of loci in turn. 

























Involved in ovary/follicle development 
[65, 66] + + + + + + + 
rs12947774 
(near AKAP1) 
Involved in meiotic maturation of 
porcine oocytes (meiotic resumption 
and MII development) [117] 





Variants in DLPGA2 are associated 
with meiotic recombination outside of 
hotspots [75]; TDRP may be involved 
in spermatogenesis [76] 
+ + + + + + + 
rs1855111 
(near CXCL12) 
Involved in oocyte development in 
sheep [118] 
+  + + + + + 
rs12652455 
(near RICTOR) 
Involved in folliculogenesis in mice 
[119] +  + +  + + 
rs117746305 
(in FZD3) 
May be involved in follicle growth and 




Possibly involved in folliculogenesis in 
mice [121] - - - -  -  
rs200216460 
(in ARMC4) 
circARMC4 is involved in porcine 
oocyte meiotic maturation [122] 




Also known as ZIP10; involved in 
oocyte zinc regulation and meiotic 
maturation in mice [123] 
+   +  + + 
rs35288347 
(near AURKC) 
involved in chromosome alignment 
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meiotic spindle formation in mouse 
oocytes (with knockdown leading to 
meiotic spindle disruption, PSSC, and 
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present in human meiotic oocytes [74]; 
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matrix of cumulus cells in mice [72] 
-  - -    
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Involved in folliculogenesis in mice 
[125] -  - -    
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Also known as BAF200; may be 
involved in epigenetically 
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homologous recombination repair of 
double strand breaks; a specific role in 
meiosis has not been proven [126, 127] 
+  + +    
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(near CEP70 
Centrosomal protein involved in 
mitotic spindle assembly [128] (about 
500kb from signal) 





gross aneuploidies in mouse 
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mitotic segregation defects in human 
colon cancer cells [129] 
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(in MYO10) 
Involved in mitotic and meiotic spindle 
assembly [79, 130-133] 
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Involved in mitotic division [139] 







Associated with genome-wide 
recombination counts [15]; meiotic 
cohesin subunit [50-53, 55] *  *  *   
MND1 Involved in processing meiotic double 
strand breaks and recombination [29, 
57-60] 
*      ** 
SYCE2 Component of central element of 
synaptonemal complex  **   *   
SYCP2 Lateral element component of 





Associated with genome-wide 
recombination counts [15]; near FZD2, 
which may be involved in follicle 
growth, oocyte maturation in mice 
[140, 141] 
 *      
REC114 Influences meiotic recombination by 
involvement in double-strand break 
location (in a manner dependent on 
distance to the telomere on short 
chromosomes in yeast) [28, 142] 
 *      
REC8 Meiotic cohesin subunit [54, 55]   *     
SYCP1 Transverse filament component of 
synaptonemal complex    **    
HORMAD2 Involved in chromosome 






Associated with genome-wide 
recombination counts [15, 75]; also 
involved with oocyte quality control 
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Associated with genome-wide 
recombination counts [15] 
    *   
HORMAD1 Involved in chromosome 
synapsis/meiotic recombination [26, 
27] 
     *  
SPO11 Involved in meiotic double strand 
break formation [28]      *  
Large + and - denote formally significant associations for prior GWAS variants (p < 0.05/7 = 7.14x10-3), with the effect allele conferring risk or protection for nondisjunction, 
respectively. Small + and – denote nominal significance (p < 0.05). ** Denotes significant associations for candidate loci (correcting for the number of independent variants tested 
and the number of subgroups). * Denotes nominal significance for candidate regions (correcting for the number of independent variants only). 
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3.4.1 Candidate Loci 
The 37 candidate loci we tested comprise two groups. The first group consists of 13 regions 
surrounding SNPs found by Kong et al. to be associated with global recombination counts in a 
large Icelandic population [15]. The second group consists of 24 candidate genes involved with 
recombination and other meiotic processes (see [18] for a discussion of these). The “heatmap” in 
Figure 3.3 summarizes the results across all candidate loci. Of these, 22 associations across 14 loci 
were nominally significant (p < 0.05/number of SNPs at locus), though only 5 associations across 
4 loci passed the conservative threshold. Figures 3.4 and 3.5 show LocusZoom plots for some of 
these loci, noting that these loci represent small windows around specific SNPs and genes, not 
single-SNP loci. Additional LocusZoom plots are included in the Supporting Information. 
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Figure 3.3 Summary of stratified analysis results for 37 candidate loci 
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3.4.1.1 Results for Candidate Loci Associated with Genome-Wide Recombination Counts 
Among the 13 recombination-associated loci tested in our previous analysis, we found 
three that were statistically significantly associated with maternal MI or MII nondisjunction: 
RAD21L, CCDC43 and SMEK1. In these stratified analyses, none of those loci showed subgroup 
associations that passed the conservative significance threshold. In order to describe which 
subgroups may have driven the previous significant associations, we simply identify the strongest 
subgroup associations (formally significant or not). The RAD21L (rs450739) locus was previously 
associated with all maternal cases and MI cases. The results of the MI subgroup analyses, while 
not passing the conservative significance threshold, suggest that the MI R0 and MI younger 
subgroups may have primarily driven the previous association. The CCDC43 (rs75502650) locus 
was previously associated with both MI and MII maternal nondisjunction. Among the MI 
subgroups, the single telomeric exchange subgroup shows the strongest effect; among the MII 
subgroups, none is even nominally significant. Though CCDC43 itself has not otherwise been 
linked to meiotic processes, the nearby gene FZD2 may be involved in ovarian follicle/oocyte 
development [140, 141]. The SMEK1 (rs10135595) region was the only candidate locus of this 
group that showed a significant association in our previous GWAS (in the MI vs. MII contrast) but 
showed only weak associations in the seven subgroups in the stratified analyses. 
We observed nominally significant associations for two candidate loci not found significant 
in our previous analyses. The CPLX1 (rs74434767) locus was nominally significant in the MII 
centromeric subgroup. The RNF212 locus (specifically, windows surrounding rs4045481 and 
rs658846, located in that gene) was nominally significantly associated in the MII centromeric and 
MII older subgroups. Regional association plots for the CCDC43, RAD21L, and CPLX1/RNF212 
loci are shown in Figure 3.4. 
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Figure 3.4 LocusZoom plots for selected associations in candidate loci for global recombination (CCDC43, 
RAD21L, and CPLX1/RNF212 loci) 
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3.4.1.2 Results for Candidate Loci Involved with Meiotic Processes 
Among the 24 meiosis/recombination gene loci tested for maternal nondisjunction in our 
previous work, four were significant: SYCP1 (MI vs. MII), SYCP2 (MII and MI vs. MII), SYCE2 
(MI), and MND1 (MII and MI vs. MII). In our stratified analyses, we found significant associations 
in three of these four genes and in an additional gene not previously found associated with maternal 
nondisjunction (HORMAD2). The stratified analyses honed in on associations with specific 
subgroups in genes that play a role in the synaptonemal complex: SYCP1 (MI older), SYCP2 (the 
strongest associations, only nominally significant, were in the MI older and MII younger 
subgroups), and SYCE2 (significant for MI single telomeric and nominally for MII centromeric). 
HORMAD2, which plays a role in coordinating progression of chromosome synapsis with meiotic 
recombination, was significant in the MII centromeric and MII older subgroups. Regional 
association plots for SYCP1, SYCP2, and MND1 are shown in Figure 3.5, and the remaining loci 
are shown in the supporting information. 
There were several nominally significant associations in genes that were not previously 
significantly associated with maternal nondisjunction. Some of these associations involved genes 
with a role in DNA double strand breaks, the precursor to recombination. These include SPO11, 
that was nominally significant in the MII younger subgroup, REC114 that was nominally 
significant in the MI single telomeric group and MND1 that was nominally significant in the MI 
R0 and MII older subgroups. Lastly, REC8, a component of the meiotic cohesin complex, was 
nominally significantly associated in the MI younger subgroup. 
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Figure 3.5 LocusZoom plots for selected associations in candidate genes involved in meiotic processes (SYCP1, 
SYCP2, and MND1) 
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3.4.2 Prior chromosome 21 nondisjunction GWAS associations 
Based on our previous study design using four analyses to understand MI- and MII-specific 
risk factors, 48 SNPS were nominated as associated with nondisjunction in MI, MII, or both. In 
the present study we performed stratified analyses of these SNPs. For each prior association, we 
investigated whether the strength and direction of that SNP’s association varied across the seven 
strata, as summarized in Figure 3.6. Examples of forest plots summarizing the associations at four 
selected loci are shown in Figure 3.7 (note that for three of the four loci shown, the effect allele 
generally confers risk; for the VEGFA locus, the effect allele appears protective). Below we discuss 
the results in detail, grouping the SNPs according to their prior associations. The Supporting 




Figure 3.6 Summary of stratified analysis results for 48 previous nondisjunction GWAS loci 
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3.4.2.1 Results for Top Associations from Previous All Maternal (MI and MII) Errors 
Combined Analysis 
Among the 13 variants previously identified from the combined MI and MII mothers vs. 
fathers analysis, we observed consistent estimated directions of effect for all seven subgroups (i.e., 
for each SNP, either all odds ratios were estimated to be < 1 or all were estimated to be > 1, though 
confidence interval widths varied). This is unsurprising, given that these variants were identified 
because they were associated with the phenotype of maternal nondisjunction, combining both MI 
and MII errors. However, it is also possible that strong effects in one or more subgroup “drive” 
these associations, with weak or null effects in others. Here we saw that the MI R0, MI younger, 
and MI older subgroups (three of the larger subgroups) passed the conservative significance 
threshold (p < 7.14x10-3) for 12, 11, and 10 of the 13 variants, respectively. The two smallest 
subgroups (MI single telomeric and MII centromeric) each passed the conservative threshold for 
only one subgroup. Given the lack of heterogeneity in the point estimates, the pattern of 
significance we observe across subgroups appears broadly consistent with homogeneous effects 
with low power in smaller subgroups (though our analysis is not designed to prove this). 
Here we highlight some associated SNPs that occur near genes that play roles in follicle or 
oocyte development. rs11535058 near SLC39A10 (also known as ZIP10, involved in the oocyte-
to-egg transition [123]) was significantly associated in the MI R0 and older subgroups as well as 
the MII younger and older subgroups (Figure 3.6, Maternal MI and MII (combined), locus #3). 
rs12652455 near RICTOR (involved in folliculogenesis in mice [119]) was significantly associated 
in all but the MI telomeric and MII centromeric subgroups (Figure 3.6, Maternal MI and MII 
(combined), locus #9). rs148846406 near EPB41L3 (Figure 3.6, Maternal MI and MII (combined), 
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locus #10) was significantly associated in the three largest subgroups (MI R0, MI younger, MII 
older). EPB41L3 may have a role in folliculogenesis [121].  
No loci passed the conservative threshold for across all seven subgroups, though two 
attained nominal significance (p < 0.05) in all subgroups: rs12947774 (near AKAP1, which has a 
role in porcine oocyte maturation [117]; Figure 3.6, Maternal MI and MII (combined), locus #7) 
and rs1612273 (near DLGAP2, found to be associated with recombination outside of hotspots [75]; 
also near TDRP, possibly involved in spermatogenesis [76]; Figure 3.6, Maternal MI and MII 
(combined), locus #8). Another variant at this locus is discussed below as an MII association. 
In our previous analyses, several of the strongest associations from the combined MI and 
MII analysis also showed evidence of an effect in the stratified MI and MII error analyses, 
sometimes at a nearby variant rather than at the same variant. The most significant association 
from our previous GWAS was rs10948101 (Figure 3.6, Maternal MI and MII (combined), locus 
#1), near VEGFA (involved in folliculogenesis [65, 66]), which was significant in the three largest 
subgroups (MI R0, MI younger, and MI older). Another SNP nearby (rs10948100, Figure 3.6, 
Maternal MI errors locus #1) showed the same pattern. Similarly, rs117746305 (Figure 3.6, 
Maternal MI and MII (combined), locus #6) in FZD3 was near rs76740710, an MII-associated 
locus (Figure 3.6, Maternal MII errors locus #2). Recent research has shown that Frizzled 3 may 
have a role in follicular development and oocyte maturation [120]. These two FZD3 variants were 
significantly associated with nondisjunction in all but the MI telomeric and MII centromeric 
subgroups. 
3.4.2.2 Results for Top Associations from Previous Maternal MI Errors Analysis 
Among the 10 MI-specific prior associations, there appears to be little evidence of different 
effects across the MI R0, MI younger, or MI older groups. Only in one instance does the direction 
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of a point estimate differ among subgroups. rs35288347 near AURKC (involved in chromosome 
alignment and other meiotic processes [124]; Figure 3.6, Maternal MI errors locus #2) shows 
significance in all MI subgroups except the single telomeric exchange subgroup. rs4649043 and 
rs2467011 (Figure 3.6, Maternal MI errors locus #3 and #6, near RUNX3 and ARID2, respectively) 
follow the same pattern. RUNX3 is involved in folliculogenesis in mice [125]. ARID2 (also known 
as BAF200) may be involved in epigenetically reprogramming oocytes and has been shown to 
promote homologous recombination repair of double strand breaks, though a specific role in 
meiosis has not been proven [126, 127]. rs9984132, similarly, passes the conservative significance 
threshold in the MI R0 and MI older subgroups, but attains only nominal significance in the MI 
younger subgroup (Figure 3.6, Maternal MI errors loci #10). This association is near PCNT, which 
encodes pericentrin, a protein involved in mammalian somatic cell centrosome assembly and 
meiotic spindle formation in mouse oocytes, with knockdown leading to meiotic spindle 
disruption, PSSC, and aneuploidy [73].  
The smallest subgroup, MI single telomeric, passes the conservative significance threshold 
in only one case, generally tracking the other subgroups but with a wider confidence interval. This 
significant association occurs at rs437933 (Figure 3.6, Maternal MI errors locus #4), discussed 
further below. Though none of the MII subgroups show a significant effect (p < 7.14x10-3) at any 
of these MI loci, the MII younger subgroup confidence intervals for three MI loci may suggest a 
(possibly weaker) effect, tracking the significant effects in the MI R0, MI younger, and MI older 
subgroups, (rs437933, rs16847735, and rs984968; Figure 3.6, Maternal MI errors locus #4, #5, 
and #9). Of these, rs437933 (mentioned above), which has the strongest MI single telomeric 
association among all 48 loci, is located near THEG5 (“testis highly expressed protein 5”), which 
is poorly characterized; rs16847735 is located about 500kb from CEP70 (a centrosomal protein 
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involved in mitotic spindle assembly [128]); and rs984968 is in MACROD2 
(haploinsufficiency/knockout of which causes gross aneuploidies in mouse embryonic fibroblasts 
and various mitotic segregation defects in human colon cancer cells [129]). 
3.4.2.3 Results for Top Associations from Previous Maternal MII Errors Analysis 
Of 13 variants associated with maternal MII nondisjunction in our previous analyses, eight 
show generally consistent effects across all MII subgroups and little evidence of effect in any MI 
groups. For all 13 loci, effect directions are the same across all MII subgroups, though the MII 
centromeric group generally has larger confidence intervals and lower significance, reflecting its 
smaller sample size. For instance, rs115281615 near CPEB2 shows consistent MII subgroup 
associations with no significant associations in any MI subgroups (Figure 3.6, Maternal MII errors 
locus #7). This gene is necessary for meiotic maturation of porcine oocytes, particularly for 
reaching MII metaphase [138]. rs62359711 near DAB2 (Figure 3.6, Maternal MII errors locus #8), 
which may be involved in oocyte maturation, particularly at MII [136, 137], follows a similar 
pattern. rs73178888 (Figure 3.6, Maternal MII errors locus #9), also significantly associated with 
nondisjunction in all three MII subgroups, is located near DLGAP2 but is not in linkage 
disequilibrium with rs1612273 (discussed above in the combined MI and MII analysis); therefore, 
these associations may represent independent signals. rs9966603 (Figure 3.6, Maternal MII errors 
locus #10) is located near HAUS1 (also known as HEI-C), which is required for proper mitotic 
division, with depletion resulting in an abnormal mitotic spindle [139]. The strongest association 
for the MII centromeric group was at rs12981234 (Figure 3.6, Maternal MII errors locus #3). This 
SNP lies in a gene-rich region that includes XAB2. XAB2 has numerous functions, including 
mitotic cell cycle regulation (with knockdown leading to errors in chromosome alignment and 
segregation) as well as end resection in homologous recombination [134, 135]. 
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Several of the remaining loci may suggest shared effects in some MI subgroups, with the 
added caveat that some of these MI associations are only nominally significant, without passing 
the conservative threshold. These include rs76740710 in FZD3, mentioned above (Figure 3.6, 
Maternal MII errors locus #2), significant in the MI R0, MI younger, and MI older subgroups. 
Another example is rs200216460 in ARMC4, which is significantly associated in all MII subgroups 
as well as the MI telomeric group, with nominal significance in the MI older group (Figure 3.6, 
Maternal MII errors locus #4). Recent work has shown that ARMC4 circular RNAs are crucial to 
oocyte maturation in pigs [122]. The top MII variant, rs1855111 (in TMEM72-AS1; Figure 3.6, 
Maternal MII errors locus #1), attained nominal significance in the MI R0, MI younger, and MI 
older groups, but did not pass the conservative threshold. Although neither TMEM72-AS1 nor the 
nearby TMEM72 appear to be involved in meiosis, the gene CXCL12 (470kb downstream) may 
play a role in ovine oocyte development [118]. Finally, rs2560850 in MYO10 is significantly 
associated in the MII centromeric and MII younger subgroups and attains nominal significance in 
the MI older and MII older subgroups (Figure 3.6, Maternal MII errors locus #12). In addition to 
roles in mitotic spindle function and mitotic progression, MYO10 is required for meiotic spindle 
assembly [79, 130-133]. 
3.4.2.4 Results for Top Associations from Previous Maternal MI Errors vs. MII Errors 
Analysis 
For the variants we found associated from the “MI vs. MII” previous analyses, we expected 
to observe evidence of effects in the opposite direction among the associations in MI and the MII 
subgroups. Among the 12 variants analyzed, six followed this pattern: they were at least nominally 
significantly associated in at least one MI subgroup and at least one MII subgroup, with opposite 
directions of effect. Of these six, four suggested (at least) a contrast between the MI R0 group and 
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the MII older group (Figure 3.6, Maternal MI errors vs MII errors locus #6, #7, #8 and #10). 
Another suggested opposite significant effects for the MI younger and MII older subgroups (Figure 
3.6, Maternal MI errors vs MII errors locus #4); the last of these contrasted the MI telomeric and 
older groups with the MII younger and older groups (Figure 3.6, Maternal MI errors vs MII errors 
locus #2). The remaining six variants did not show the expected pattern for an “MI vs. MII” variant, 
although there were noted associations within MI error (Figure 3.6, Maternal MI errors vs MII 
errors locus #12) or MII error (Figure 3.6, Maternal MI errors vs MII errors locus #1, #3, #5, #9 
and #11) subgroups. 
3.5 DISCUSSION 
The purpose of this study was to better understand maternal meiotic disjunction of 
chromosome 21 by following up our previous findings from a GWAS and candidate gene study. 
In that study, we stratified maternal nondisjunction based on MI- or MII-derived errors (see 
Introduction and below). Here, we further examined heterogeneity within those groups based on 
known risk factors, namely maternal age and recombination profile on chromosome 21 in order to 
gain further insight into potential modes of action for each gene. While our study was not designed 
to prove or disprove any particular mechanism, it does complement recent important research by 
investigating how common genetic variation may contribute to these mechanisms. Below we 
discuss our results within the context of the proposed mechanisms and the limitations of our 
approach. 
The simplest conceptual category of genetic risk factors is those that cause general 
nondisjunction risk. Such variants would broadly increase the risk of an error across all subgroups 
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of MI and MII nondisjunction, irrespective of risk factors such as age and recombination. The prior 
GWAS associations we followed up on here are enriched for variants near oocyte development or 
folliculogenesis genes (Table 2), and the results of our stratified analyses indicate that such genes 
are consistent with this model of contributing to meiotic nondisjunction errors broadly. For 
example, the VEGFA, AKAP1, and the DLGAP2 (rs1612273) loci all have at least nominally 
significant associations with the same effect directions across all subgroups. Additionally, the 
SLC39A10, RICTOR, FZD3, CXCL12, ARMC4, and EPB41L3 loci may follow a similar pattern, 
but with small sample sizes limiting power in some subgroups. Conversely, it should be noted that 
consistent associations across subgroups for a given locus do not necessarily imply the same 
mechanism across subgroups, since such results are also consistent with pleiotropic effects. 
We also observed results that are consistent with standard MI and MII errors and their 
associated recombination profiles (for MI, either no observed recombination on chromosome 21, 
or a single telomeric, exchange; pericentromeric recombination for MII). Both types of errors are 
associated with advanced maternal age. With respect to the altered recombination patterns, the MI-
associated patterns are independent of maternal age while MII-associated pericentromeric 
recombination increases with increasing maternal age [11, 13]. Our results suggest that genetic 
variants may contribute to standard MI or MII nondisjunction mechanisms (these could be either 
the common variants we tested or unobserved variants, possibly rare, in linkage disequilibrium 
with them). This interpretation is based on functions of the implicated genes and the patterns of 
associations across subgroups. For example, the AURKC locus is broadly associated with 
nondisjunction in MI (significantly in the younger, older, and R0 subgroups). While the functions 
of AURKC in meiosis are complex and not fully understood, loss of AURKC function in mouse 
oocytes can cause misalignment of chromosomes at MI and aneuploidy in MII oocytes [124]. On 
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the other hand, the XAB2 and HAUS1/HEI-C loci were both broadly associated with 
nondisjunction in MII subgroups. XAB2 and HAUS1 are required for proper mitotic division, which 
has important similarities with MII division. These results are consistent with a hypothetical 
mechanism in which defects in machinery shared with mitotic processes cause failure of sister 
chromatids to segregate at MII. 
Additionally, several candidate loci were associated specifically with nondisjunction in MI 
or MII recombination subgroups, suggesting these loci could contribute to standard MI or MII 
errors by increasing the likelihood of “susceptible” recombination patterns on chromosome 21. 
For instance, the previously observed SYCE2 (a synaptonemal complex element) association 
appears to be driven primarily by the MI single telomeric and the MII centromeric subgroups. 
Another possible example is REC114, nominally significantly associated only in the MI single 
telomeric subgroup, which influences meiotic recombination in yeast by controlling double-strand 
break location in a manner dependent on distance to the telomere on short chromosomes [142]. 
(The nominal REC114 association should be interpreted cautiously, since REC114 was not 
significantly associated with nondisjunction in our previous study). Contrasting the SYCE2 and 
REC114 associations with the loci discussed above as possible candidates for standard 
nondisjunction, we observe evidence of potentially important genetic heterogeneity. Whereas 
SYCE2 and REC114 appear to be associated only in recombination-defined subgroups, the 
AURKC, XAB2, and HAUS1/HEI-C loci are broadly associated across MI or MII subgroups, with 
significant associations both in subgroups defined by recombination and those not. Together these 
observations suggest that some variants in/near meiosis genes could contribute “narrowly” to 
nondisjunction risk by contributing specifically to aberrant recombination, while others may 
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contribute broadly, independently adding to (or possibly interacting with) recombination-
associated risk within a particular stage of meiosis. 
Several other results in the recombination-defined subgroups are more difficult to interpret 
and merit discussion. We note that among the global recombination count loci identified by Kong 
et al. [15], only the RAD21L locus was even nominally associated in the MI R0 subgroup, where 
we might have expected several other recombination-count genes to be associated, given evidence 
that lower genome-wide recombination is associated with aneuploidy in oocytes [111]. Another 
counterintuitive finding is that two previous synaptonemal complex gene associations appeared to 
be driven primarily by subgroups not defined by recombination profile (specifically, SYCP1 for 
the MI older subgroup, and SYCP2 for the MI older and MII younger subgroups). 
Our results give limited insight into issues around PSSC and RS mechanisms. The 
simplistic classification of meiotic nondisjunction events as “MI errors” or “MII errors” based 
solely on whether homologous chromosomes vs. sister chromatids are passed from mother to child 
is an inference from incomplete data, since effectively only one product of female meiosis is 
observed (the oocyte). Without further information about the chromosomal content of the other 
products of meiosis (the first and second polar bodies), the sequence of events leading to 
aneuploidy in the oocyte cannot be directly inferred. Indeed, other mechanisms such as premature 
separation of sister chromatids (PSSC) or reverse segregation (RS) are major causes of aneuploidy 
in oocytes but are indistinguishable from standard MI or MII errors in our study. It is important to 
note that although both mechanisms involve separation of sister chromatids in MI, the relative 
rates of PSSC and RS suggest that the latter is not simply due to two independent occurrences of 
the former [111]. This is further corroborated by the more extensive loss of cohesion involved in 
RS than in PSSC. These observations suggest that the two mechanisms could either share genetic 
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factors (influencing, e.g., cohesion in general) or have some unique factors (affecting, e.g., 
cohesion at the centromere vs. chromosome-wide). 
These additional mechanisms likely explain some of the heterogeneity in our results. Since 
PSSC can lead to apparent MI or MII errors, variants affecting the risk of PSSC may be represented 
in our results as signals shared by MI and MII subgroups. Additionally, since lack of recombination 
may contribute to PSSC and RS [111], signals shared with the MI R0 subgroup may implicate 
these mechanisms. This could explain, for instance, why the previous MND1 association appears 
to be driven by the MI R0 and MII older groups. Our candidate gene results also suggest that age-
related associations in cohesin genes could represent PSSC and/or RS. For instance, REC8 is 
nominally associated in the MI younger group (with a similar but non-significant effect in the MII 
younger group; note, however, that REC8 was not significant in our previous analysis). The prior 
association with the cohesin subunit gene RAD21L (also associated with genome-wide 
recombination [15]) appeared to be driven by associations in the MI R0, MI younger, and MII 
centromeric groups. These signals suggest that variants at this locus could contribute to multiple 
mechanisms: increasing the risk of MI nondisjunction due to lack of recombination, promoting 
sister chromatid separation through age-related degradation of cohesin, or exacerbating 
pericentromeric recombination. 
Among the potentially heterogeneous associations we observed in the GWAS loci were 
several involving maternal age subgroups. rs437933, rs16847735, and rs984968 (near THEG5, 
CEP70, and MACROD2, respectively), which are each significantly associated with 
nondisjunction in the MI R0, MI younger, and the MI older groups, and nominally associated in 
the MII younger group but with null effects in the MII older group. rs2560850 (near MYO10) was 
significantly associated with nondisjunction in MII subgroups and nominally in the MI older 
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group, but with no effect in the MI younger group. If genuine, these heterogeneous signals could 
represent genetic effects contributing to apparent MI and MII errors through age-dependent effects 
on PSSC. But further work is needed to characterize these complex associations, especially given 
that some are only nominally significant. 
It is important to note that this study had limited ability to detect heterogeneous effects 
among subgroups precisely because of how the loci were chosen. The 48 maternal meiotic 
nondisjunction associations we investigated first came to our attention because our prior GWAS 
that stratified only by type of nondisjunction error: MI or MII. In order to be statistically significant 
in this previous analysis, it is expected that effects within each error type were in the same 
direction; otherwise, the heterogeneity would be masked. Thus it is unsurprising that we did not 
generally observe statistically significant associations with opposite directions of effect for MI and 
MII error subgroups. 
3.6 CONCLUSION 
Our stratified analyses succeeded in uncovering heterogeneity in earlier genetic 
associations. While our approach of classifying errors as MI or MII in origin does not enable us to 
infer nondisjunction mechanisms in particular cases, our results provide insight into how variation 
in oocyte development and meiotic processes may contribute to specific nondisjunction 
mechanisms. In future studies, larger sample sizes will enable efforts to replicate the reported 
associations and perhaps even genome-wide scans in the smallest subgroups. In the future it may 
also be possible to perform a similar study in which all products of female meiosis are recovered, 
allowing inference of the nondisjunction mechanism in each case and more refined stratifications. 
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Finally, we are planning analyses of altered maternal recombination on chromosome 21 as an 
outcome in itself, which may have higher power for detecting genetic variants contributing to 
nondisjunction risk and may therefore clarify our understanding of how recombination affects that 
risk. 
3.7 APPENDIX: METHODS FOR CALLING MEIOTIC STAGE OF 
NONDISJUNCTION AND RECOMBINATION EVENTS 
3.7.1 Overview 
We used a different method for calling stage of origin and recombination events in trios 
(with child and both parents genotyped) than in dyads (with mother and child genotyped, but not 
the father), since the latter contain less information. Because our analyses focus on recombination 
in oocytes, we did not call recombination events in father-child dyads. Our overall approach for 
calling recombination in trios and dyads is summarized in Figure 3.8. 
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Figure 3.8 Overview of methods for calling recombination in trios and dyads 
3.7.2 Calling Stage of Origin in Trios 
Determining the stage of origin of trisomy 21 in a complete parent-child trio first entails 
comparing the parents’ and their child’s genotypes at informative markers on chromosome 21. 
Briefly, a marker is informative if the parent in which the error was derived (the mother, in our 
application) is heterozygous and the genotypes of both parents together make it possible to infer 
whether the parent of origin passed two identical versus two different alleles to the child. In the 
former case, the marker is scored as “reduced to homozygosity” (R), and in the latter “not reduced 
to homozygosity” (N). Assuming there are no genotyping errors, recombination events are 
indicated by changes in zygosity between adjacent markers. 
After scoring markers (STRs and SNPs) on chromosome 21 in this way, we determined 
the stage of meiotic error by considering the scores of proximal markers (those nearest the 
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centromere) on the long arm of the chromosome. Assuming no recombination events occur 
between the centromere and the most proximal marker, the stage of origin is indicated by the 
zygosity of that proximal marker: N for an MI error, or R for an MII error. 
In almost all trios, the most proximal informative marker was a SNP, but in a few cases the 
stage of origin was called based on an STR. In nine trios, the stage of origin call was determined 
by a single SNP or STR (that is, the zygosity changed at the very next marker). In the 15 trios 
where the parent of origin was unclear based on SNP genotypes (due to mosaicism or poor 
genotyping), no attempt was made to call the stage of origin. These were excluded from our 
analyses. 
3.7.3 Calling Recombination Events in Trios 
As described above, recombination events are indicated by changes in zygosity between 
nearby ordered markers. In the presence of genotyping error, however, not every change in 
zygosity truly represents recombination. For instance, the pattern RRRRRNRRRRR likely reflects 
a genotyping error at a single SNP rather than two extremely close recombination events, whereas 
RRRRRNNNNNRRRRR shows stronger evidence of two recombination events (since multiple, 
independent genotyping errors in a row are less likely). Thus there is a tradeoff between over- and 
under-calling recombination from changes in SNP scores. 
Here we used a simple algorithm to call recombination in the presence of genotyping errors. 
At each informative SNP in the interior of the chromosome, we considered a moving window 
centered at that SNP and consisting of the information from seven SNPs: the SNP itself and the 
three nearest SNPs on either side. SNPs are coded as N=1 and R=2 and then averaged for each 
window (Figure 3.9). 
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Figure 3.9 Method for calling recombination events in a full trio 
For the three most informative proximal SNPs on the chromosome arm and the three most 
telomeric SNPs, we had to use a different method to calculate the seven-SNP-window score. We 
made the assumption that the chance for a more extreme recombinant (i.e., one closer to the 
centromere or one beyond the most telomeric SNP) was highly unlikely. Thus, we simply counted 
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the most proximal (telomeric) SNP more than once toward these averages. This procedure yielded 
a moving average at each SNP, for the purpose of smoothing out “noise” due to genotyping errors.  
Recombination events were called when the moving average of each window crossed a 
threshold of 1.5 (equivalent to the local 7-SNP “majority vote” changing). The exact location of 
the recombination was called as halfway between the two informative SNPs flanking the event. In 
the nine trios where the stage of error was called on the basis of a single SNP or STR, 
recombination was also called on the basis of that single proximal SNP or STR. In the two cases 
where an STR was used, the recombination location was approximated with the position of the 
most proximal SNP. 
To call multiple recombinants along the chromosome using a window size of seven SNPs 
effectively placed a lower bound of four SNPs for the plausible distance between two 
recombination events. This bears out the intuition (arrived at through trial and error) that patterns 
such as RRRRRNNNNNRRRRR and RRRRRNNNRNRRRRR represent true double-
recombination events (the latter with some “noise” due to genotyping error), but that 
RRRRRNNNRRRRR may not. 
The number of recombination events for each trio was also recorded. In two trios with 
excessive “noise” in the scores, recombination events could not be called with confidence. In all, 
recombination events were called for 613 trios. Plots showing the recombination profiles are 
included in the Supporting Information. 
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3.7.4 Overview of Inference in Dyads 
In addition to the 613 full trios in which we successfully called recombination events, we 
also attempted to call stage of origin and recombination events in 94 mother-child dyads. Our 
approach is similar to that used above for trios: scoring informative markers and calculating 
moving averages. The analysis differs because the absence of paternal genotype information, 
which results in less informative marker scoring. While markers can still be scored as R in dyads 
(e.g., mother=AT; child=TTT), the N state cannot be directly inferred by comparing the genotypes 
of mother and child (e.g., mother=AT; child=AAT). However, this state (X) provides partial 
information. Calling stage and recombination therefore entails making plausible inference about 
the true state when X is observed. For instance, when we observe RRRRXRRRR or 
RRRRXXXXRRRR, we can assume that X masks R in the first case with more confidence than 
in the second case. Observing RRRRXXXXXXXXXXXXXXXXRRRR, it becomes likely that 
there is a double recombinant event and that the series of Xs is masking N. Using this intuition, 
we tend to infer a state of N where the density of X is high relative to R. 
Because our study focuses on maternal nondisjunction and recombination in oocytes, we 
did not attempt to determine stage of origin or call recombination events in father-child dyads. 
3.7.5 Calling Stage of Origin in Dyads 
Our method for calling stage of meiotic error has been described elsewhere [18]. Briefly, 
following the logic described above, we used the ratio of the number of X to the number of R SNPs 
near the centromere to predict the true zygosity there (R or N). The number of SNPs to include 
and the classification threshold for this ratio were treated as parameters to be optimized. The full 
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trios were used as a training set to obtain the optimal parameters, since masking the father’s 
genotypes in a trio yields a mother-child dyad (with stage of meiotic origin determined above). 
3.7.6 Calling Recombination Events in Dyads 
To call recombination events in the 94 mother-child dyads, we used an algorithm 
combining the logic used for calling recombination in the full trios and the logic for calling stage 
of origin in the dyads (see Figure 3.8). 
First, informative SNPs on chromosome 21 were scored as R or X in each dyad. As in the 
trios, we formed a window centered at each informative SNP. Using the coding R=2 and X=3, a 
moving average for a window was calculated using each SNP (as before, the most proximal and 
distal SNP were counted more than once in order to provide a full window around 
telomeric/centromeric “edge” SNPs).  
As above, we sought to call a recombination event whenever the moving average crossed 
a threshold between adjacent SNPs (using average position of the two SNPs flanking the event). 
The number of SNPs in the window and the threshold were treated as parameters to be optimized, 
the number of possible thresholds depending on the number of SNPs in the window.  
We used the full trios as a training set to optimize these parameters, treating the 
recombination calls already obtained for the trios as the truth. Each trio represents a mother-child 
dyad plus a father, so by masking the father’s genotypes and coding SNPs (R=2, X=3) we obtained 
613 pseudo-dyads with “true” recombination calls. 
For each window size (ranging from 7 to 41 SNPs, using odd numbers of SNPs), a moving 
average was calculated across the chromosome. SNPs near the ends of the chromosome were given 
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extra weight, as above. For each possible threshold, recombination events were called in each trio 
(halfway between any two SNPs where the threshold was crossed). 
Because an interval that is reduced to homozygosity in a dyad will be represented by a 
more or less random streak of 2s and 3s, the moving average may fluctuate rapidly even over a 
short distance. Therefore we used several filtering steps to avoid oversensitivity in calling tight 
double recombination events and recombination events near the ends of the chromosome. Tight 
double recombination calls were filtered out if they were separated by fewer than seven 
informative SNPs or less than 500kb. More stringent filtering was applied to tight double 
recombination calls representing a middle segment not reduced to homozygosity (i.e. a middle 
segment with a high proportion of partially informative SNPs coded X). These were filtered out 
unless supported by a streak of 40 consecutive X SNPs. Recombination calls based on inferring 
non-homozygosity near the ends of the chromosome were filtered out if not supported by a streak 
of 12 X SNPs at the centromeric end or 40 X SNPs near the telomeric end. We applied these 
filtering steps both in training our algorithm in the pseudo-dyads and in making final 
recombination calls for the dyads. 
For each possible pair of parameter values (i.e., the number of SNPs in a window and the 
threshold for calling a recombinant), the recombination calls were scored numerically on each 
pseudo-dyad. The “best” pair of parameter values was defined to be the one that maximized the 
total score across all pseudo-dyads in the training set. We calculated the score as follows. 
 
Figure 3.10 Scoring recombination calls in the training set trios 
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For simplicity, all types of correct/incorrect recombinant calls were weighed equally in a 
trio (see Figure 3.10). In the case of a pseudo-dyad with k=0 true recombination events, a score of 
+1 was added if the algorithm correctly called 0 events in that “dyad”; otherwise -1 was deducted 
for each incorrectly-called event. In the case of k > 1 true events, +1 was awarded for each of the 
k events detected by a call within 1 Mb, -1 was deducted for each of the k events not detected by 
a call within 1 Mb, and -1 was deducted for each additional event erroneously called. Figure 3.11 
shows an example of calling recombination and scoring in a masked dyad. Plots showing 
recombination-calling in all 613 pseudo-dyads are included in the Supporting Information. 
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Figure 3.11 Method for calling recombination events in a masked-trio dyad 
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The optimal window size was found to be 25 SNPs, and the optimal threshold for calling 
recombination was 2.74. Figure 3.12 shows the score attained for each window-size/threshold pair. 
We therefore applied the algorithm to the 94 dyads using these parameters and (summarizing the 
steps described above), adding extra weight to SNPs near the end of the chromosome, calling 
events halfway between SNPs where the threshold was crossed, and filtering out tight double 
recombination and proximal/distal events. We did not find it necessary to exclude any dyads for 
excessive “noise” (i.e., implausibly large recombination counts). Plots showing recombination 
calls for the dyads are included in the Supporting Information.  
 
Figure 3.12 Optimizing recombination calls on the pseudo-dyads 
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4.1 SUMMARY OF FINDINGS 
This dissertation has three aims: performing a GWAS and candidate gene study to find 
genetic risk factors for maternal meiotic nondisjunction of chromosome 21, calling recombination 
events on chromosome 21 in trios and dyads, and then dissecting the genetic associations, 
stratifying by recombination profile (as well as maternal age and meiotic stage of error). These 
aims were successful. The initial study (Chapter 2) found plausible associations with candidate 
genes such as the synaptonemal complex gene SYCP2 and the cohesin subunit gene RAD21L as 
well as suggestive GWAS associations near genes such as VEGFA, SLC39A10, AURKC, and 
MYO10. The results were consistent with the existence of MI- and MII-specific risk factors as well 
as shared risk factors. In the second aim (Chapter 3, Appendix) we called recombination events on 
chromosome 21 in trios and found that those calls can be used in turn to train an accurate algorithm 
for calling recombination in mother-child dyads. In the third aim (Chapter 3) we performed 
stratified analyses of the candidate and GWAS loci in subgroups of mothers defined by 
recombination profile, age, and meiotic stage of error. The results are consistent with models in 
which some variants may, for example, confer general nondisjunction risk across all subgroups, 
some may act broadly within MI or MII, and some could cause or exacerbate particular 
“susceptible” recombination patterns. While these analyses are not designed to prove or disprove 
any models or mechanisms, they could prove to be a first step toward describing the genetic 
architecture of meiotic nondisjunction. 
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4.2 STRENGTHS AND LIMITATIONS 
This study is the first genome-wide association study of meiotic nondisjunction, a 
surprisingly common occurrence in humans with important implications for health and 
reproduction. We found evidence that plausible loci may confer risk of meiotic errors, possibly in 
a mechanism-specific manner. In particular, the candidate gene analysis successfully combined 
GWAS data with biological insights to begin dissecting the genetics of meiotic nondisjunction. 
Given the modest sample size of this study, it is unsurprising that the GWAS did not reach 
genome-wide significance (whereas some candidate loci did meet a less stringent Bonferroni 
threshold). As in any genetic association study, the results of our genome-wide, candidate gene, 
and follow-up stratified analyses need to be replicated in an independent cohort.  
Our work here with a population-based cohort complements previous studies of aneuploidy 
in oocytes, which have often been performed in the context of assisted reproduction and therefore 
may not be representative of the general population. However, we only analyzed common SNPs 
in a mostly European-background group. Therefore, in addition to studying rare and structural 
variants, we should also study meiotic nondisjunction in other populations. 
4.3 FUTURE ANALYSES 
In addition to replication studies of the same phenotype in other populations and studying 
rarer variation, several other follow-up approaches may be feasible, some more purely 
epidemiological and others that could combined standard genetic epidemiology with exciting new 
techniques. 
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First, we plan further genome-wide association studies of recombination phenotypes in this 
cohort. In those analyses, genetic variants will be tested for association with “susceptible” 
recombination patterns on chromosome 21 and the number of recombination events on the 
chromosome. An interesting extension would be to phase the genotypes in parent-child trios, which 
would enable recombination-calling on the other chromosomes, in turn allowing us to investigate 
genome-wide recombination in mothers who experienced meiotic nondisjunction of chromosome 
21. 
Second, recent molecular and imaging advances have partially overcome some of the 
technical and ethical challenges of studying the origins of aneuploidy in humans. These include 
the novel procedure of “meiomapping”, which combines maternal autosomal DNA with SNP array 
data from the first and second polar bodies along with oocyte (or early embryo) [144]. Analysis of 
all of the products of meiosis in addition to maternal DNA accomplishes several important tasks. 
First, it enables inference of the mechanism in an instance of meiosis that has resulted in 
aneuploidy (see Figure 1.1). Second, it allows inference of meiotic stage of error and genome-wide 
recombination patterns. Together, these full-meiotic-product data have yielded important new 
insights that could not be fully addressed through mathematical modeling, such as disentangling 
rate estimates for specific error mechanisms and establishing selection for recombinant chromatids 
at MII [111, 112]. 
The genetic epidemiology approach of this dissertation could be extended to the context of 
meiomapping by performing more refined stratified genome-wide analyses to identify risk loci for 
specific error mechanisms (possibly further stratified by recombination pattern and/or maternal 
age). By stratifying into what may be the most biologically meaningful subsets and by accessing 
meiotic products relatively early (before a large proportion of aneuploidies are spontaneously 
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aborted), such studies may have better power to find associations. This may also enable us to 
identify interactions of genetics with age for mechanisms in which maternal age plays a role.  
Recent research has corroborated the underlying the U-shaped aneuploidy vs. age curve, 
where the mechanism of aneuploidies for MI errors in the younger mothers  (the left side of the 
“U”) are less clear than those in older mothers [113]. If sufficient samples were available, a 
meiomapping and GWAS approach in this group could help us infer the error mechanisms and 
genetic risk factors for MI errors in young women. A limitation of the meiomapping approach 
would be that such data, often obtained from assisted reproduction contexts, may not be 
representative of human meioses in general. Another complementary approach may be enabled by 
advances in single-cell RNA-seq that enable sensitive detection of mitotic or meiotic aneuploidies 
in embryos [145]. 
Finally, another direction would be to perform molecular genetics studies of loci identified 
here (particularly GWAS loci). For example, if knockout/knockdown of homologous genes in 
model organisms causes aberrant recombination or higher aneuploidy rates, this would constitute 
important corroboration of our results and could help to associate particular genes and variants 
with specific error mechanisms. 
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